HK1204656A1 - 涉及 抑制劑分子的方法和組合物 - Google Patents
涉及 抑制劑分子的方法和組合物Info
- Publication number
- HK1204656A1 HK1204656A1 HK15105287.4A HK15105287A HK1204656A1 HK 1204656 A1 HK1204656 A1 HK 1204656A1 HK 15105287 A HK15105287 A HK 15105287A HK 1204656 A1 HK1204656 A1 HK 1204656A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- mirna
- methods
- inhibitor molecules
- compositions involving
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/344—Position-specific modifications, e.g. on every purine, at the 3'-end
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
- C12N2310/3527—Other alkyl chain
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/353—Nature of the modification linked to the nucleic acid via an atom other than carbon
- C12N2310/3535—Nitrogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/533—Physical structure partially self-complementary or closed having a mismatch or nick in at least one of the strands
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
- C12N2320/12—Applications; Uses in screening processes in functional genomics, i.e. for the determination of gene function
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/50—Methods for regulating/modulating their activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/10—Production naturally occurring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dispersion Chemistry (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62717104P | 2004-11-12 | 2004-11-12 | |
US64963405P | 2005-02-03 | 2005-02-03 | |
US68373605P | 2005-05-23 | 2005-05-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1204656A1 true HK1204656A1 (zh) | 2015-11-27 |
Family
ID=37570916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15105287.4A HK1204656A1 (zh) | 2004-11-12 | 2015-06-03 | 涉及 抑制劑分子的方法和組合物 |
Country Status (11)
Country | Link |
---|---|
US (25) | US8173611B2 (zh) |
EP (21) | EP2808389A1 (zh) |
JP (11) | JP2008519606A (zh) |
AU (1) | AU2005333165B2 (zh) |
CA (7) | CA2587189A1 (zh) |
DK (1) | DK2302055T3 (zh) |
ES (13) | ES2503743T3 (zh) |
HK (1) | HK1204656A1 (zh) |
PL (1) | PL2302055T3 (zh) |
SI (1) | SI2302055T1 (zh) |
WO (1) | WO2006137941A2 (zh) |
Families Citing this family (382)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2385123B1 (en) | 2001-09-28 | 2018-04-25 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Microrna molecules |
JP5435864B2 (ja) * | 2004-05-28 | 2014-03-05 | アシュラジェン インコーポレイテッド | マイクロrnaに関与する方法および組成物 |
WO2006027776A1 (en) * | 2004-09-07 | 2006-03-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial |
US20090186353A1 (en) * | 2004-10-04 | 2009-07-23 | Rosetta Genomics Ltd. | Cancer-related nucleic acids |
US7825229B2 (en) * | 2005-03-25 | 2010-11-02 | Rosetta Genomics Ltd. | Lung cancer-related nucleic acids |
US7642348B2 (en) * | 2004-10-04 | 2010-01-05 | Rosetta Genomics Ltd | Prostate cancer-related nucleic acids |
DK2302055T3 (da) * | 2004-11-12 | 2014-10-13 | Asuragen Inc | Fremgangsmåder og sammensætninger involverende miRNA og miRNA-inhibitormolekyler |
US8592384B2 (en) | 2005-04-04 | 2013-11-26 | The Board Of Regents Of The University Of Texas System | Micro-RNA's that regulate muscle cells |
CN101535331B (zh) * | 2005-04-29 | 2013-01-30 | 洛克菲勒大学 | 人类微小rna以及用于抑制人类微小rna的方法 |
EP1904111A4 (en) * | 2005-06-03 | 2009-08-19 | Univ Johns Hopkins | COMPOSITIONS AND METHODS FOR DECREASING MICROARN EXPRESSION FOR THE TREATMENT OF NEOPLASIA |
JP5489459B2 (ja) * | 2005-08-01 | 2014-05-14 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 乳癌の診断、予後及び治療のためのマイクロrnaに基づいた方法及び組成物 |
WO2007033023A2 (en) | 2005-09-12 | 2007-03-22 | The Ohio State University Research Foundation | Compositions and methods for the diagnosis and therapy of bcl2-associated cancers |
JP2009511482A (ja) * | 2005-10-05 | 2009-03-19 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | Wwox遺伝子、同じものを含むベクター、および癌の治療における使用 |
BRPI0619755A2 (pt) | 2005-12-12 | 2011-10-18 | Univ North Carolina | micrornas que regulam a proliferação e diferenciação de células musculares |
ES2554531T3 (es) * | 2006-01-05 | 2015-12-21 | The Ohio State University Research Foundation | Procedimientos basados en los microARN para el diagnóstico, pronóstico y tratamiento del cáncer de pulmón |
AU2016203848B2 (en) * | 2006-01-05 | 2017-12-14 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
ES2465600T3 (es) * | 2006-01-05 | 2014-06-06 | The Ohio State University Research Foundation | Métodos basados en microARN y composiciones para el diagnóstico y tratamiento de cánceres sólidos del páncreas |
EP2586454B1 (en) | 2006-01-05 | 2014-10-08 | The Ohio State University Research Foundation | MicroRNA expressions abnormalities in pancreatic endocrine and acinar tumors |
WO2007109236A2 (en) | 2006-03-20 | 2007-09-27 | The Ohio State University Research Foundation | Microrna fingerprints during human megakaryocytopoiesis |
KR101407707B1 (ko) | 2006-04-03 | 2014-06-19 | 산타리스 팔마 에이/에스 | Anti-mirna 안티센스 올리고뉴클레오타이드를 함유하는 약학적 조성물 |
CN102851291B (zh) | 2006-04-03 | 2016-03-09 | 斯特拉有限责任公司 | 包含抗微小rna反义寡核苷酸的药物组合物 |
CN101657547B (zh) | 2006-07-13 | 2016-04-27 | 俄亥俄州立大学研究基金会 | 用于诊断和治疗结肠癌相关疾病的基于微小rna的方法和组合物 |
EP2434017A3 (en) | 2006-08-01 | 2012-09-05 | Board of Regents of the University of Texas System | Identification of a micro-RNA that activates expression of beta-myosin heavy chain |
EP2046970B2 (en) † | 2006-08-04 | 2020-04-29 | Dublin City University | A method of producing recombinant biological products |
WO2008025073A1 (en) * | 2006-08-28 | 2008-03-06 | The University Of Western Australia | Method of modulation of expression of epidermal growth factor receptor (egfr) involving mirna |
JPWO2008029790A1 (ja) * | 2006-09-04 | 2010-01-21 | 協和発酵キリン株式会社 | 新規核酸 |
CA2663962A1 (en) * | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
US8071292B2 (en) | 2006-09-19 | 2011-12-06 | The Ohio State University Research Foundation | Leukemia diagnostic methods |
EP2086590A4 (en) | 2006-10-24 | 2011-04-06 | Univ Leland Stanford Junior | MODULATION OF A T-CELL SIGNALING THRESHOLD AND THE SENSITIVITY OF T-CELLS AGAINST ANTIGENE |
CA2667617A1 (en) | 2006-11-01 | 2008-05-08 | The Ohio State University Research Foundation | Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma |
US20080131878A1 (en) * | 2006-12-05 | 2008-06-05 | Asuragen, Inc. | Compositions and Methods for the Detection of Small RNA |
WO2008073921A2 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Mir-126 regulated genes and pathways as targets for therapeutic intervention |
EP2104737B1 (en) * | 2006-12-08 | 2013-04-10 | Asuragen, INC. | Functions and targets of let-7 micro rnas |
EP2104734A2 (en) * | 2006-12-08 | 2009-09-30 | Asuragen, INC. | Mir-20 regulated genes and pathways as targets for therapeutic intervention |
AU2007333107A1 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | miR-21 regulated genes and pathways as targets for therapeutic intervention |
CN101627121A (zh) * | 2006-12-08 | 2010-01-13 | 奥斯瑞根公司 | 作为治疗干预的靶标的miRNA调控基因和路径 |
CA2671270A1 (en) * | 2006-12-29 | 2008-07-17 | Asuragen, Inc. | Mir-16 regulated genes and pathways as targets for therapeutic intervention |
WO2008088858A2 (en) * | 2007-01-17 | 2008-07-24 | The Johns Hopkins University | Compositions and methods featuring micronas for treating neoplasia |
EP2109687B1 (en) | 2007-01-31 | 2014-06-04 | The Ohio State University Research Foundation | Micro-rna-based methods for the treatment of acute myeloid leukemia |
US9006206B2 (en) | 2007-02-27 | 2015-04-14 | Rosetta Genomics Ltd. | Composition and methods for modulating cell proliferation and cell death |
CA2699418A1 (en) * | 2007-02-27 | 2008-09-04 | Moshe Oren | Composition and methods for modulating cell proliferation and cell death |
WO2008107901A2 (en) * | 2007-03-07 | 2008-09-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial |
WO2008115387A2 (en) * | 2007-03-15 | 2008-09-25 | University Hospitals Of Cleveland | Screening, diagnosing, treating and prognosis of pathophysiologic states by rna regulation |
WO2008116267A1 (en) | 2007-03-26 | 2008-10-02 | Crc For Asthma And Airways Ltd | Therapeutic targets and molecules |
US20100273172A1 (en) * | 2007-03-27 | 2010-10-28 | Rosetta Genomics Ltd. | Micrornas expression signature for determination of tumors origin |
US20090117562A1 (en) | 2007-04-09 | 2009-05-07 | Valerie Wailin Hu | Method and kit for diagnosing Autism using gene expression profiling |
EP2142659A4 (en) * | 2007-04-30 | 2010-06-09 | Univ Ohio State Res Found | METHOD FOR THE DISTINCTION OF PANCREATIC CANCER OF NORMAL IMMERSION SPECTRUM FUNCTIONS AND CHRONIC IMMERSION IMAGING IGNITION |
EP1990414A1 (en) * | 2007-05-10 | 2008-11-12 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Means for treating inflammatory diseases, autoimmune diseases and cancer |
US20090232893A1 (en) * | 2007-05-22 | 2009-09-17 | Bader Andreas G | miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
WO2008147974A1 (en) | 2007-05-23 | 2008-12-04 | University Of South Florida | Micro-rnas modulating immunity and inflammation |
AU2008262252B2 (en) | 2007-06-08 | 2013-09-12 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Methods for determining hepatocellular carcinoma subtype and detecting hepatic cancer stem cells |
US20090227533A1 (en) * | 2007-06-08 | 2009-09-10 | Bader Andreas G | miR-34 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
US8053186B2 (en) * | 2007-06-15 | 2011-11-08 | The Ohio State University Research Foundation | Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing |
US20090012031A1 (en) * | 2007-07-03 | 2009-01-08 | The Regents Of The University Of Michigan | EZH2 Cancer Markers |
KR20100057022A (ko) | 2007-07-31 | 2010-05-28 | 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 | 마이오신 발현 및 근섬유 동일성을 제어하는 마이크로-rnas |
EP2808398A1 (en) * | 2007-07-31 | 2014-12-03 | The Ohio State University Research Foundation | Methods for reverting methylation by targeting DNMT3A and DNMT3B |
US8440636B2 (en) | 2007-07-31 | 2013-05-14 | The Board Of Regents, The University Of Texas System | Micro-RNA family that modulates fibrosis and uses thereof |
US7812003B2 (en) * | 2007-08-02 | 2010-10-12 | Safe Stephen H | Antisense microRNA and uses therefor |
ES2627059T3 (es) | 2007-08-03 | 2017-07-26 | The Ohio State University Research Foundation | Regiones ultraconservadas que codifican ARNnc |
WO2009021235A2 (en) * | 2007-08-09 | 2009-02-12 | The Regents Of The University Of Colorado | Methods and compositions for treating cancer |
CA2733676A1 (en) | 2007-08-10 | 2009-02-19 | British Columbia Cancer Agency Branch | Microrna compositions and methods for the treatment of myelogenous leukemia |
CA2926831A1 (en) | 2007-08-22 | 2009-02-26 | The Ohio State University Research Foundation | Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias |
CN101376910B (zh) * | 2007-08-27 | 2012-01-11 | 中国科学院上海生命科学研究院 | 微小rna基因在系统性红斑狼疮疾病诊断和治疗中的作用 |
EP2183393B1 (en) * | 2007-09-06 | 2014-06-11 | The Ohio State University Research Foundation | Microrna signatures in human ovarian cancer |
EP2198050A1 (en) * | 2007-09-14 | 2010-06-23 | Asuragen, INC. | Micrornas differentially expressed in cervical cancer and uses thereof |
WO2009044895A1 (ja) * | 2007-10-03 | 2009-04-09 | Kyowa Hakko Kirin Co., Ltd. | 標的遺伝子の発現を抑制する組成物 |
WO2009044899A1 (ja) * | 2007-10-03 | 2009-04-09 | Kyowa Hakko Kirin Co., Ltd. | 細胞の増殖を制御する核酸 |
CN101821391B (zh) | 2007-10-04 | 2016-04-27 | 桑塔里斯制药公司 | 微小聚体 |
CN103937876B (zh) * | 2007-10-11 | 2016-08-17 | 俄亥俄州立大学研究基金会 | 用于诊断和治疗食管腺癌的方法和组合物 |
WO2009052386A1 (en) * | 2007-10-18 | 2009-04-23 | Asuragen, Inc. | Micrornas differentially expressed in lung diseases and uses thereof |
US8911998B2 (en) | 2007-10-26 | 2014-12-16 | The Ohio State University | Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof |
WO2009058907A2 (en) | 2007-10-29 | 2009-05-07 | Isis Pharmaceuticals, Inc. | Targeting micrornas for the treatment of liver cancer |
CA2701298A1 (en) * | 2007-11-05 | 2009-05-14 | Kci Licensing Inc. | Identification of tissue for debridement |
NZ585209A (en) | 2007-11-09 | 2012-08-31 | Univ Texas | Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair |
ITRM20070595A1 (it) * | 2007-11-15 | 2009-05-16 | Univ Roma | Mirna e sirna e loro uso in terapia |
WO2009066967A2 (en) * | 2007-11-23 | 2009-05-28 | Panagene Inc. | Microrna antisense pnas, compositions comprising the same, and methods for using and evaluating the same |
JP2011505143A (ja) * | 2007-11-30 | 2011-02-24 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | マイクロrna発現プロファイリング及び肺癌における末梢血ターゲティング |
US8071562B2 (en) * | 2007-12-01 | 2011-12-06 | Mirna Therapeutics, Inc. | MiR-124 regulated genes and pathways as targets for therapeutic intervention |
WO2009086156A2 (en) * | 2007-12-21 | 2009-07-09 | Asuragen, Inc. | Mir-10 regulated genes and pathways as targets for therapeutic intervention |
KR101325186B1 (ko) | 2008-01-23 | 2013-11-07 | (주)바이오니아 | 이중가닥 miRNA를 유효성분으로 포함하는 항암제 |
JP5116026B2 (ja) | 2008-01-23 | 2013-01-09 | 富士フイルム株式会社 | 癌の検出方法および癌抑制剤 |
CA2708661A1 (en) * | 2008-01-27 | 2009-07-30 | Rosetta Genomics Ltd. | Methods and compositions for diagnosing complications of pregnancy |
EP2260110B1 (en) * | 2008-02-08 | 2014-11-12 | Asuragen, INC. | miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS |
WO2009108853A1 (en) * | 2008-02-28 | 2009-09-03 | The Ohio State University Research Foundation | MicroRNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF GASTRIC CANCER |
JP2011517932A (ja) * | 2008-02-28 | 2011-06-23 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | ヒト慢性リンパ球性白血病(ccl)と関連するマイクロrnaシグネチャーおよびその使用 |
CN104031984A (zh) * | 2008-02-28 | 2014-09-10 | 俄亥俄州立大学研究基金会 | 用于前列腺相关病症的诊断、预后和治疗的基于微rna的方法和组合物 |
US8404659B2 (en) | 2008-03-07 | 2013-03-26 | Santaris Pharma A/S | Pharmaceutical compositions for treatment of MicroRNA related diseases |
EP2265291B1 (en) * | 2008-03-17 | 2016-10-19 | The Board of Regents of The University of Texas System | Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
WO2009120712A2 (en) | 2008-03-24 | 2009-10-01 | New York University | Compositions and methods for diagnosing and treating melanoma |
WO2009154835A2 (en) * | 2008-03-26 | 2009-12-23 | Asuragen, Inc. | Compositions and methods related to mir-16 and therapy of prostate cancer |
EP2279267A4 (en) * | 2008-03-27 | 2012-01-18 | Vascular Biosciences Inc | METHOD FOR IDENTIFICATION OF NEW THERAPEUTIC CANDIDATES VIA GENE EXPRESSION ANALYSIS IN VASCULAR DISEASES |
CN102046810B (zh) * | 2008-04-07 | 2014-11-19 | 康奈尔研究基金公司 | 血管生成抑制 |
WO2009126726A1 (en) * | 2008-04-08 | 2009-10-15 | Asuragen, Inc | Methods and compositions for diagnosing and modulating human papillomavirus (hpv) |
CA2723716A1 (en) * | 2008-05-07 | 2009-11-12 | Abraxis Bioscience, Llc | Enhancement of drug therapy by mirna |
EP2285960B1 (en) | 2008-05-08 | 2015-07-08 | Asuragen, INC. | Compositions and methods related to mir-184 modulation of neovascularization or angiogenesis |
US20110178159A1 (en) * | 2008-05-08 | 2011-07-21 | Hua Gu | Inhibitory rnas that regulate hematopoietic cells |
WO2009147658A2 (en) * | 2008-06-02 | 2009-12-10 | New York University | Compositions and methods for diagnosis, prognosis and treatment of mesothelioma |
US8927207B2 (en) * | 2008-06-05 | 2015-01-06 | Research Foundation Of State University Of New York | miRNAs as therapeutic targets in cancer |
US8900627B2 (en) * | 2008-06-06 | 2014-12-02 | Mirna Therapeutics, Inc. | Compositions for the in vivo delivery of RNAi agents |
WO2009148631A1 (en) * | 2008-06-06 | 2009-12-10 | The Board Of Trustees Of The Leland Stanford Junior University | Role of mirna in t cell leukemia |
CN102149827B (zh) | 2008-06-11 | 2014-08-20 | 由卫生与公众服务部代表的美利坚合众国政府 | MiR-26家族作为肝细胞癌和对治疗的应答性的预测性标志物的用途 |
US8252534B2 (en) * | 2008-06-12 | 2012-08-28 | City Of Hope | Micro RNAs and their methods of use for the treatment and diagnosis of schizophrenia and schizophrenia spectrum disorders |
US20110077168A1 (en) * | 2008-06-17 | 2011-03-31 | Nitzan Rosenfeld | Methods for distinguishing between specific types of lung cancers |
WO2009153774A2 (en) * | 2008-06-17 | 2009-12-23 | Rosetta Genomics Ltd. | Compositions and methods for prognosis of ovarian cancer |
AU2009264170A1 (en) | 2008-06-27 | 2009-12-30 | Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Prediction of antiviral therapy response |
BRPI0913657A2 (pt) | 2008-07-01 | 2020-08-04 | Monsanto Technology Llc | constructos de dna recombinante e métodos para a modulação da expressão de um gene-alvo |
WO2010001632A1 (ja) * | 2008-07-03 | 2010-01-07 | 国立大学法人神戸大学 | 関節リウマチ関連マイクロrna |
WO2010012667A1 (en) | 2008-08-01 | 2010-02-04 | Santaris Pharma A/S | Micro-rna mediated modulation of colony stimulating factors |
KR101042052B1 (ko) * | 2008-08-05 | 2011-06-16 | 사회복지법인 삼성생명공익재단 | 항-microRNA를 포함하는 고형암 예방 또는 치료용조성물 |
US20110280861A1 (en) * | 2008-08-08 | 2011-11-17 | Massachusetts Institute Of Technology | Method for mir-125a in promoting hematopoietic stem cell self renewal and expansion |
WO2010019446A1 (en) * | 2008-08-09 | 2010-02-18 | University Of Iowa Research Foundation | Nucleic acid aptamers |
CA2733556A1 (en) * | 2008-08-11 | 2010-02-18 | The Board Of Regents Of The University Of Texas System | A micro-rna that promotes vascular integrity and uses thereof |
AU2009281969A1 (en) * | 2008-08-12 | 2010-02-18 | The Ohio State University Research Foundation | Micro-RNA-based compositions and methods for the diagnosis, prognosis and treatment of multiple myeloma |
US20120149586A1 (en) * | 2008-08-15 | 2012-06-14 | Scottsdale Healthcare | Methods of predicting the risk of recurrence of cancer |
EP2326730B1 (en) * | 2008-08-19 | 2014-03-19 | Maine Institute For Human Genetics And Health | Micro rna (mirna) and neurofibromatosis type 1 : a role in diagnosis and therapy |
WO2010033818A2 (en) | 2008-09-19 | 2010-03-25 | Immune Disease Institute, Inc. | Mirna targets |
EP2364367B8 (en) * | 2008-11-10 | 2017-08-23 | Battelle Memorial Institute | Method utilizing microrna for detecting interstitial lung disease |
US20100179213A1 (en) * | 2008-11-11 | 2010-07-15 | Mirna Therapeutics, Inc. | Methods and Compositions Involving miRNAs In Cancer Stem Cells |
US8734759B2 (en) | 2008-12-05 | 2014-05-27 | Yeda Research And Development Co. Ltd. | Methods of diagnosing and treating motor neuron diseases |
AU2009322137B2 (en) * | 2008-12-05 | 2015-09-10 | Whitehead Institute For Biomedical Research | Compositions and methods relating to miR-31 |
EP2208785A1 (en) | 2009-01-15 | 2010-07-21 | Newbiotechnic, S.A. | Methods and kits to generate miRNA- and smallRNA-expressing vectors, and its application to develop lentiviral expression libraries |
WO2010084488A1 (en) | 2009-01-20 | 2010-07-29 | Ramot At Tel-Aviv University Ltd. | Mir-21 promoter driven targeted cancer therapy |
US9493832B2 (en) | 2009-02-02 | 2016-11-15 | Cepheid | Methods of detecting sepsis |
RU2515926C2 (ru) * | 2009-02-04 | 2014-05-20 | Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем | Двойное нацеливание нп mir-208 и mir 499 в лечении заболеваний сердца |
EP2218458A1 (en) * | 2009-02-13 | 2010-08-18 | Fondazione Telethon | Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof |
US20100311815A1 (en) * | 2009-02-23 | 2010-12-09 | The Regents Of The University Of Michigan | Mir-101 cancer markers |
JP2012518997A (ja) * | 2009-02-26 | 2012-08-23 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 喫煙未経験者におけるマイクロrna、ならびに関連する材料および方法 |
WO2010107397A1 (en) * | 2009-03-19 | 2010-09-23 | Agency For Science, Technology And Research | Modulators of apoptosis and the uses thereof |
US20120087992A1 (en) * | 2009-03-20 | 2012-04-12 | Jingfang Ju | miRNAS AS THERAPEUTIC TARGETS IN CANCER |
WO2010117829A2 (en) | 2009-03-31 | 2010-10-14 | The United States Of America As Represented By The Secretary Department Of Health And Human Services | Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjögren's syndrome |
WO2010120969A1 (en) * | 2009-04-15 | 2010-10-21 | Board Of Regents, The University Of Texas System | Targeting of the mir-30 family and let-7 family as a treatment for heart disease |
EP2421970B1 (en) | 2009-04-24 | 2016-09-07 | Roche Innovation Center Copenhagen A/S | Pharmaceutical compositions for treatment of hcv patients that are non-responders to interferon |
CN102421917B (zh) * | 2009-04-29 | 2014-07-09 | 阿姆斯特丹大学学术医学中心 | 对抗、预防和/或测定心力衰竭或心力衰竭的风险的工具和方法 |
WO2010127186A1 (en) | 2009-04-30 | 2010-11-04 | Prognosys Biosciences, Inc. | Nucleic acid constructs and methods of use |
WO2010129860A2 (en) * | 2009-05-08 | 2010-11-11 | The Ohio State University Research Foundation | Microrna expression profiling and targeting in chronic obstructive pulmonary disease (copd) lung tissue and methods of use thereof |
US20130177624A1 (en) * | 2009-05-08 | 2013-07-11 | David Brian Corry | Mirna expression in allergic disease |
US8924232B2 (en) * | 2009-05-11 | 2014-12-30 | Koninklijke Philips N.V. | Device and method for comparing molecular signatures |
KR20120047214A (ko) * | 2009-05-20 | 2012-05-11 | 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 | 심근경색 후 리모델링 및 심부전에 관련된 마이크로―rna의 확인 |
CN102459598B (zh) | 2009-05-20 | 2016-06-01 | Eth苏黎世公司 | 用于代谢紊乱的靶向微小rna |
WO2010136846A1 (en) * | 2009-05-25 | 2010-12-02 | Carola Ponzetto | Differentiation therapy for sarcomas |
DK2435583T3 (da) * | 2009-05-25 | 2014-09-29 | Universit Degli Studi Di Roma La Sapienza | miR-31 VED BEHANDLING AF DUCHENNES MUSKELDYSTROFI |
US10421961B2 (en) | 2009-06-10 | 2019-09-24 | Exostem Biotec Ltd | Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells |
US20100322909A1 (en) | 2009-06-17 | 2010-12-23 | The University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Th1-associated micrornas and their use for tumor immunotherapy |
US8962583B2 (en) | 2009-06-25 | 2015-02-24 | The Brigham And Women's Hospital, Inc. | Treatment of inflammatory diseases using miR-124 |
WO2011012136A1 (en) * | 2009-07-28 | 2011-02-03 | Exiqon A/S | A method for classifying a human cell sample as cancerous |
FR2948687B1 (fr) * | 2009-07-29 | 2015-09-04 | Centre Nat Rech Scient | Utilisation de microarn pour le traitement de pathologies respiratoires chroniques |
WO2011014697A1 (en) * | 2009-07-31 | 2011-02-03 | The Translational Genomics Research Institute | Methods of assessing a risk of cancer progression |
WO2011017408A1 (en) * | 2009-08-05 | 2011-02-10 | The Ohio State University Research Foundation | Anti-mir-1 therapy for wound healing |
CN102762731B (zh) * | 2009-08-05 | 2018-06-22 | 库尔纳公司 | 通过抑制针对胰岛素基因(ins)的天然反义转录物来治疗胰岛素基因(ins)相关的疾病 |
EP2283846A1 (en) | 2009-08-12 | 2011-02-16 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | miRNA compounds for treatment of prostate carcinoma |
US8796238B2 (en) | 2009-09-17 | 2014-08-05 | Sigma-Aldrich Co. Llc | Short RNA mimetics |
WO2011047147A1 (en) * | 2009-10-14 | 2011-04-21 | Baylor College Of Medicine | Microrna mirna-31 as a therapeutic approach for the treatment of cancer |
US8841273B2 (en) * | 2009-10-28 | 2014-09-23 | Board Of Regents, The University Of Texas System | Methods and compositions for anti-EGFR treatment |
EP3118334A1 (en) | 2009-11-04 | 2017-01-18 | DiamiR, LLC | Methods of using small rna from bodily fluids for diagnosis and monitoring of neurodegenerative diseases |
JP5960060B2 (ja) | 2009-11-23 | 2016-08-02 | ジ・オハイオ・ステート・ユニバーシティ | 腫瘍細胞の増殖、遊走および浸潤に影響を与えるために有用な物質および方法 |
JP2013511559A (ja) * | 2009-11-24 | 2013-04-04 | ザ ユニバーシティ オブ ウェスタン オーストラリア | 上皮成長因子受容体リガンドのモジュレーション |
EP2327783A1 (en) * | 2009-11-27 | 2011-06-01 | Universitätsklinikum Freiburg | Pharmaceutical composition comprising miRNA-100 and its use in the modulation of blood vessel growth |
US8354520B2 (en) * | 2009-12-10 | 2013-01-15 | Kaohsiung Medical University | Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug |
US20120315640A1 (en) | 2009-12-21 | 2012-12-13 | Hidetoshi Tahara | Senescence marker, method for evaluating senescence inhibitor, and cancer inhibitor |
WO2011084815A1 (en) * | 2009-12-21 | 2011-07-14 | Board Of Trustees Of Southern Illinois University | Inhibition of ubc9-mediated cancer cell invasion and metastasis |
EP2518144B1 (en) * | 2009-12-21 | 2015-08-05 | Hiroshima University | Aging marker, method for evaluating aging inhibitor, and cancer inhibitor |
WO2011079299A1 (en) * | 2009-12-23 | 2011-06-30 | The George Washington University | Compositions and methods for identifying autism spectrum disorders |
EP2341145A1 (en) * | 2009-12-30 | 2011-07-06 | febit holding GmbH | miRNA fingerprint in the diagnosis of diseases |
US8846631B2 (en) | 2010-01-14 | 2014-09-30 | Regulus Therapeutics Inc. | MicroRNA compositions and methods |
WO2011091209A1 (en) * | 2010-01-21 | 2011-07-28 | North Carolina State University | Small molecule modifiers of microrna mir-122 |
JP2011188849A (ja) * | 2010-02-18 | 2011-09-29 | Okayama Univ | 抗腫瘍効果を有するmiR−7発現プラスミド |
US8841269B2 (en) * | 2010-02-23 | 2014-09-23 | Creighton University | Polynucleotides for use in treating and diagnosing cancers |
EP2542678B1 (en) * | 2010-03-04 | 2017-04-12 | InteRNA Technologies B.V. | A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS THERAPEUTIC USES IN CANCER ASSOCIATED WITH EMT |
WO2011111715A1 (ja) * | 2010-03-09 | 2011-09-15 | 協和発酵キリン株式会社 | 細胞周期を制御する核酸 |
US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
AU2011237729B2 (en) | 2010-04-05 | 2014-04-03 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
DK2561078T3 (en) | 2010-04-23 | 2019-01-14 | Cold Spring Harbor Laboratory | NEW STRUCTURALLY DESIGNED SHRNAs |
WO2011150420A1 (en) * | 2010-05-28 | 2011-12-01 | Baylor College Of Medicine | Modified gold nanoparticles for therapy |
EP2576785A4 (en) | 2010-06-04 | 2014-12-24 | Univ Texas | REGULATION OF METABOLISM BY MIR-378 |
EP2580327B1 (en) * | 2010-06-09 | 2014-01-22 | Chanel Parfums Beauté | Inhibitors of micro-rnas for use for preventing and/or attenuating skin ageing and/or for hydrating skin |
NZ704322A (en) * | 2010-07-06 | 2016-07-29 | Interna Technologies Bv | Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
CN103189511B (zh) * | 2010-07-12 | 2016-10-12 | 国立大学法人鸟取大学 | 利用siRNA导入的新型hiPSC制作法 |
US8580513B2 (en) * | 2010-07-20 | 2013-11-12 | Trustees Of Dartmouth College | Methods for determining response to neoadjuvant therapy and survival using MicroRNA-10b |
WO2012012716A2 (en) | 2010-07-23 | 2012-01-26 | Regulus Therapeutics, Inc. | Targeting micrornas for the treatment of fibrosis |
US10385314B2 (en) | 2010-08-16 | 2019-08-20 | Exostem Biotec Ltd. | Methods of generating oligodendrocytes and cell populations comprising same |
WO2012023132A1 (en) * | 2010-08-16 | 2012-02-23 | Brainstem Biotech Ltd. | Methods of generating oligodendrocytes and cell populations comprising same |
RU2013104137A (ru) | 2010-08-17 | 2014-09-27 | Университэ Де Женева | Изоформы bard1 при раке легкого и колоректальном раке и их применение |
US8642342B2 (en) | 2010-08-19 | 2014-02-04 | Regents Of The University Of Michigan | Methods for regulating neural differentiation |
EP2426217A1 (en) * | 2010-09-03 | 2012-03-07 | Centre National de la Recherche Scientifique (CNRS) | Analytical methods for cell free nucleic acids and applications |
US9006195B2 (en) * | 2010-09-13 | 2015-04-14 | California Institute Of Technology | Regulation of hematopoietic stem cell functions through microRNAs |
CN103221542A (zh) * | 2010-09-27 | 2013-07-24 | 萨班哲大学 | miRNA用于诊断、预防、治疗和追踪涉及巨自噬异常的疾病的用途 |
US8933051B2 (en) | 2010-09-30 | 2015-01-13 | University Of Zurich | Treatment of B-cell lymphoma with microRNA |
WO2012065049A1 (en) * | 2010-11-12 | 2012-05-18 | The Ohio State University Research Foundation | Materials and methods related to microrna-21, mismatch repair, and colorectal cancer |
EP2638912A4 (en) | 2010-11-12 | 2015-01-21 | Nat Univ Corp Ehime Univ | COMPOSITIONS WITH AN ANTISENSE OLIGONUCLEOTIDE AGAINST MICRO RNA |
CA2817982C (en) | 2010-11-15 | 2020-06-30 | The Regents Of The University Of Michigan | Controlled release mucoadhesive systems |
JP6155194B2 (ja) | 2010-11-17 | 2017-06-28 | インターペース ダイアグノスティックス リミテッド ライアビリティ カンパニー | 良性甲状腺新生物と悪性甲状腺新生物を区別するためのバイオマーカーとしてのmiRNA |
US11344505B1 (en) | 2010-12-01 | 2022-05-31 | Gowey Research Group, Pllc | Herbal formulations of carnivorous plants and methods for treating inflammation |
US11414663B2 (en) | 2010-12-01 | 2022-08-16 | Gowey Research Group, Pllc | Micro-RNA profiling, compositions, and methods of treating diseases |
EP3214185A1 (en) * | 2010-12-01 | 2017-09-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for predicting the outcome of colon cancer by analysing mirna expression |
US10744151B1 (en) * | 2010-12-01 | 2020-08-18 | Gowey Research Group PLLC | Micro-RNA profiling, compositions, and methods of treating diseases |
US10758578B2 (en) | 2010-12-01 | 2020-09-01 | Gowey Research Group PLLC | Herbal formulations of carnivorous plants and methods for treating inflammation |
CA2817371A1 (en) | 2010-12-15 | 2012-06-21 | Miragen Therapeutics | Microrna inhibitors comprising locked nucleotides |
EP2658972A4 (en) * | 2010-12-15 | 2015-05-06 | Medimmune Llc | MELANOMA TREATMENT |
EP2654801B1 (en) * | 2010-12-20 | 2017-11-01 | Agency For Science, Technology And Research | Targeting glioma stem cells by sequence-specific functional inhibition of pro-survival oncomir-138 |
EP2474617A1 (en) | 2011-01-11 | 2012-07-11 | InteRNA Technologies BV | Mir for treating neo-angiogenesis |
WO2012106586A1 (en) | 2011-02-03 | 2012-08-09 | Mirna Therapeutics, Inc. | Synthetic mimics of mir-124 |
WO2012106591A1 (en) | 2011-02-03 | 2012-08-09 | Mirna Therapeutics, Inc. | Synthetic mimics of mir-34 |
CA2844596A1 (en) * | 2011-02-07 | 2012-08-16 | Biomirna Holdings Ltd. | Micro-rna biomarkers and methods of using same |
CN103561750A (zh) | 2011-03-07 | 2014-02-05 | 俄亥俄州立大学 | 通过microRNA-155(miR-155)诱导的增变活性使炎症与癌症关联 |
EP3792359A1 (en) * | 2011-03-30 | 2021-03-17 | Transine Therapeutics Limited | Functional nucleic acid molecule and use thereof |
EP2691548B1 (en) * | 2011-03-31 | 2017-11-22 | University of Houston | Microrna 130a,b as a tumor suppressor and sensitizing agent for chemotherapy |
GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
WO2012140234A1 (en) | 2011-04-13 | 2012-10-18 | Vib Vzw | Modulation of mirna in diseases with aberrant angiogenesis |
AU2012245628B2 (en) | 2011-04-18 | 2016-09-22 | Diamir, Llc | Methods of using miRNA from bodily fluids for early detection and monitoring of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) |
WO2012145743A1 (en) * | 2011-04-22 | 2012-10-26 | University Of Houston | Microrna-140-5p as a tumor suppressor and sensitizing agent for chemotherapy |
UA115652C2 (uk) | 2011-04-25 | 2017-12-11 | Реґюлус Терап'Ютікс Інк. | Сполука, що містить модифікований олігонуклеотид, комплементарна mir-21 |
EE201100037A (et) * | 2011-05-16 | 2012-12-17 | Tartu Ülikool | MikroRNAde kasutamine biomarkeritena ja sihtmrkidena raku proliferatiivsete omaduste m?jutamiseks ja meetod ning komplekt nende ekspressioonitaseme tuvastamiseks |
US20140221648A1 (en) * | 2011-06-27 | 2014-08-07 | Galderma Research & Developement | Th17 differentiation markers for acne and uses thereof |
BR112013033617B1 (pt) | 2011-06-27 | 2021-10-26 | Galderma Research & Development | Uso de mrna, método para o diagnóstico de acne, métodos para o monitoramento da progressão ou variação de acne e da eficácia de um tratamento para tratar acne, e de triagem in vitro para a identificação de inibidores de diferenciação de células th17 |
US8747860B2 (en) * | 2011-07-06 | 2014-06-10 | Institute For Systems Biology | Methods and compositions to modulate antiviral and immune activity responses |
EP2740266A1 (en) | 2011-08-01 | 2014-06-11 | Thomson Licensing | Telepresence communications system and method |
CA2844012C (en) | 2011-08-04 | 2021-03-16 | Yeda Research And Development Co. Ltd. | Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions |
US8987224B2 (en) | 2011-08-05 | 2015-03-24 | Baylor College Of Medicine | MicroRNA-198 as a tumor suppressor in pancreatic cancer |
US20140199402A1 (en) | 2011-08-12 | 2014-07-17 | Alexander Schmidt | Novel compounds for the treatment of inflammatory bowel disease |
WO2013032962A2 (en) * | 2011-08-28 | 2013-03-07 | The Board Of Trustees Of The Leland Stanford Junior University | Micro rnas to treat stroke, ischemic brain injury, traumatic brain injury, and neurodegenerative disease |
US9434944B2 (en) | 2011-08-31 | 2016-09-06 | University Of Zurich | Modulators of miR-323-3p for the prevention or treatment of rheumatoid arthritis |
CA2844577A1 (en) | 2011-09-13 | 2013-03-21 | Ottawa Hospital Research Institute | Microrna inhibitors |
WO2013040251A2 (en) | 2011-09-13 | 2013-03-21 | Asurgen, Inc. | Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease |
KR20140091688A (ko) | 2011-10-06 | 2014-07-22 | 미라젠 세러퓨틱스 인코포레이티드 | 마이크로rna 조절에 의한 전신 에너지 항상성의 제어 |
CN104364390B (zh) | 2011-10-14 | 2016-08-24 | 俄亥俄州立大学 | 与卵巢癌相关的方法和材料 |
EP2584040A1 (en) | 2011-10-17 | 2013-04-24 | Pharmahungary 2000 Kft. | Compounds for treatment of ischemic injury |
WO2013065791A1 (ja) * | 2011-11-02 | 2013-05-10 | 公立大学法人大阪市立大学 | 遺伝子発現抑制用二本鎖核酸分子 |
JP2015504847A (ja) * | 2011-11-30 | 2015-02-16 | シーダーズ−サイナイ メディカル センター | 前立腺癌骨転移および薬剤耐性肺癌を治療するためのマイクロrnamir−409−5p、mir−379、およびmir−154*の標的化 |
CN105722993A (zh) * | 2011-12-01 | 2016-06-29 | 俄亥俄州国家创新基金会 | 与结肠直肠癌的nsaid化学预防相关的材料和方法 |
JP2015501645A (ja) * | 2011-12-10 | 2015-01-19 | オハイオ・ステイト・イノベーション・ファウンデーション | 肺がんの腫瘍発生および化学療法耐性を低減するために有用なmiRNAならびに関連する組成物および方法 |
CN104619353A (zh) * | 2011-12-13 | 2015-05-13 | 俄亥俄州国家创新基金会 | 与miR-21和miR-29a相关的方法和组合物、外切体抑制和癌症转移 |
ITRM20110685A1 (it) * | 2011-12-23 | 2013-06-24 | Internat Ct For Genetic En Gineering And | Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci |
CN104685065B (zh) | 2012-01-20 | 2017-02-22 | 俄亥俄州立大学 | 浸润性和预后的乳腺癌生物标志物标签 |
EP2844745A2 (en) | 2012-02-22 | 2015-03-11 | Brainstem Biotec Ltd. | Generation of neural stem cells and motor neurons |
EP3401393B1 (en) | 2012-02-22 | 2020-02-19 | Exostem Biotec Ltd | Micrornas for the generation of astrocytes |
WO2013133863A1 (en) | 2012-03-09 | 2013-09-12 | Thomson Licensing | Distributed control of synchronized content |
AU2013251696B2 (en) | 2012-04-25 | 2018-11-15 | Sanofi | MicroRNA compounds and methods for modulating miR-21 activity |
US9598694B2 (en) | 2012-05-02 | 2017-03-21 | The Board Of Regents Of The University Of Texas System | Micro-RNAs involved in macular degeneration |
US9334498B2 (en) | 2012-05-10 | 2016-05-10 | Uab Research Foundation | Methods and compositions for modulating MIR-204 activity |
US9663784B2 (en) | 2012-05-26 | 2017-05-30 | Bonac Corporation | Single-stranded nucleic acid molecule for regulating expression of gene having delivering function |
US9163235B2 (en) | 2012-06-21 | 2015-10-20 | MiRagen Therapeutics, Inc. | Inhibitors of the miR-15 family of micro-RNAs |
EP2864482A4 (en) | 2012-06-21 | 2016-02-10 | Miragen Therapeutics Inc | OLIGONUCLEOTIDE INHIBITORS COMPRISING A BLOCKED NUCLEIC ACID PATTERN |
CN104603272B (zh) * | 2012-07-06 | 2017-11-07 | 宝生物工程株式会社 | 能够产生腺伴随病毒载体的细胞 |
EP2877186A4 (en) | 2012-07-27 | 2016-08-31 | Agency Science Tech & Res | METHOD FOR PROMOTING WOUND HEALING |
JP6340366B2 (ja) | 2012-07-31 | 2018-06-06 | イェダ リサーチ アンド デベロップメント カンパニー リミテッド | 運動ニューロン疾患を診断および処置する方法 |
EP2703498B1 (en) * | 2012-08-29 | 2015-01-14 | Chanel Parfums Beauté | Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing |
EP2702998A1 (en) | 2012-08-31 | 2014-03-05 | IMBA-Institut für Molekulare Biotechnologie GmbH | Therapeutic and diagnostic miRNA regulator in kidney disease |
WO2014043159A1 (en) * | 2012-09-11 | 2014-03-20 | New York University | Sera based mirnas as non-invasive biomarkers in melanoma |
UA116639C2 (uk) | 2012-10-09 | 2018-04-25 | Рег'Юлес Терап'Ютікс Інк. | Способи лікування синдрому альпорта |
EP3901280A1 (en) | 2012-10-17 | 2021-10-27 | Spatial Transcriptomics AB | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
US9944991B2 (en) | 2012-11-02 | 2018-04-17 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for diagnosis, prognosis and treatment of hematological malignancies |
US9340787B2 (en) * | 2012-11-15 | 2016-05-17 | Yale University | Compositions and methods of using micro RNAs |
US20140243387A1 (en) * | 2012-12-18 | 2014-08-28 | Icahn School Of Medicine At Mount Sinai | Methods for improving cardiac contractility |
DK2963125T3 (da) * | 2013-02-15 | 2020-10-12 | Univ Nat Corp Tokyo Medical & Dental | Terapeutisk middel til behandling af en cancer, hvor NRF2 er stabiliseret |
WO2014164753A1 (en) * | 2013-03-11 | 2014-10-09 | Emory University | Methods and compositions for managing vascular conditions |
US9006200B2 (en) * | 2013-03-13 | 2015-04-14 | Asbestos Diseases Research Foundation | MicroRNA-based approach to treating malignant pleural mesothelioma |
US20160032383A1 (en) * | 2013-03-15 | 2016-02-04 | Albert Einstein College Of Medicine Of Yeshiva University | PANEL OF microRNA BIOMARKERS IN HEALTHY AGING |
EP2968567A2 (en) | 2013-03-15 | 2016-01-20 | Mirna Therapeutics, Inc. | Combination cancer treatments utilizing micrornas and egfr-tki inhibitors |
WO2014151835A1 (en) | 2013-03-15 | 2014-09-25 | Miragen Therapeutics, Inc | Locked nucleic acid inhibitor of mir-145 and uses thereof |
WO2014140856A2 (en) | 2013-03-15 | 2014-09-18 | Graham Lord | Mir-142 and antagonists thereof for treating disease |
WO2014168616A1 (en) | 2013-04-10 | 2014-10-16 | Thomson Licensing | Tiering and manipulation of peer's heads in a telepresence system |
JP2016169158A (ja) * | 2013-06-14 | 2016-09-23 | 北海道公立大学法人 札幌医科大学 | 大腸癌を治療および/または診断するための組成物ならびにその利用 |
GB201310755D0 (en) * | 2013-06-17 | 2013-07-31 | Ucl Business Plc | Therapy |
EP3011691B1 (en) | 2013-06-20 | 2022-11-30 | InterDigital CE Patent Holdings | System and method to assist synchronization of distributed play out of control |
AU2014302702A1 (en) | 2013-06-24 | 2015-12-17 | Mirna Therapeutics, Inc. | Biomarkers of miR-34 activity |
EP4234716A3 (en) | 2013-06-25 | 2023-12-06 | Prognosys Biosciences, Inc. | Methods for determining spatial patterns of biological targets in a sample |
US9862943B1 (en) * | 2013-06-27 | 2018-01-09 | California Institute Of Technology | Long noncoding RNAs and cell reprogramming and differentiation |
WO2015020122A1 (ja) * | 2013-08-08 | 2015-02-12 | 国立大学法人 大阪大学 | 尿路上皮癌の診断または治療剤 |
KR101566586B1 (ko) * | 2013-08-21 | 2015-11-16 | 서울대학교산학협력단 | miRNA를 표적으로 하는 뇌전증 또는 발작 관련 질환의 예방 또는 치료용 약학 조성물 및 방법 |
EP3049522A2 (en) * | 2013-09-26 | 2016-08-03 | Friedrich Miescher Institute for Biomedical Research | Tools and methods using mirna 182, 96 and/or 183 for treating pathologies |
US20150089870A1 (en) * | 2013-10-01 | 2015-04-02 | Wayne State University | Population control of invasive plant species and restoration of native plant communities |
KR101598070B1 (ko) * | 2013-10-17 | 2016-02-26 | 한국과학기술연구원 | 마약 중독 예방 및 치료용 약제학적 조성물 |
ES2836133T3 (es) * | 2013-10-28 | 2021-06-24 | Icahn School Med Mount Sinai | Composiciones y métodos para modular la excitabilidad neuronal y el comportamiento motor |
KR101559131B1 (ko) * | 2013-11-18 | 2015-10-07 | 한국원자력의학원 | miRNA를 포함하는 방사선 민감성 증진용 조성물 |
CA2931082C (en) | 2013-11-18 | 2024-01-23 | Diamir, Llc | Methods of using mirnas from bodily fluids for detection and monitoring of parkinson's disease (pd) |
EP3178943B1 (en) | 2013-12-17 | 2018-10-03 | Csir | A method for identification of anti-hiv human mirna mimics and mirna inhibitors and anti-hiv pharmaceutical compounds |
WO2015099122A1 (ja) | 2013-12-26 | 2015-07-02 | 学校法人東京医科大学 | 遺伝子発現制御のための人工ミミックmiRNAおよびその用途 |
WO2015099188A1 (ja) * | 2013-12-27 | 2015-07-02 | 株式会社ボナック | 遺伝子発現制御のための人工マッチ型miRNAおよびその用途 |
CA2935022A1 (en) * | 2013-12-27 | 2015-07-02 | Bonac Corporation | Artificial match-type mirna for controlling gene expression and use therefor |
US10125365B2 (en) | 2014-02-05 | 2018-11-13 | Yeda Research And Development Co. Ltd. | Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions |
WO2015133637A1 (ja) * | 2014-03-07 | 2015-09-11 | 国立大学法人京都大学 | マイクロrna封入ナノ粒子及びその医薬用途 |
EP3126496A1 (en) | 2014-04-01 | 2017-02-08 | Mirna Therapeutics, Inc. | Microrna dosing regimens |
EP3409794B1 (en) * | 2014-05-02 | 2021-03-24 | Ruprecht-Karls-Universität Heidelberg | Circulating mirnas as early detection marker and prognostic marker |
ES2850281T3 (es) * | 2014-06-26 | 2021-08-26 | Icahn School Med Mount Sinai | Método para diagnosticar el rechazo agudo subclínico y clínico mediante el análisis de conjuntos de genes predictivos, un agente terapéutico para usar en el tratamiento y kits para determinar la expresión |
EP3170706A4 (en) * | 2014-07-15 | 2018-03-28 | Mitsuba Corporation | Brushless wiper motor |
LU92499B1 (en) | 2014-07-16 | 2016-01-18 | Univ Muenster Wilhelms | Mirna 320a as biomarker for inflammatory bowel disease |
ES2558262B2 (es) | 2014-08-01 | 2016-07-14 | Universidad Católica De Valencia "San Vicente Mártir" | Método de diagnóstico de fibromialgia basado en microRNAs |
US9487783B2 (en) | 2014-08-07 | 2016-11-08 | Regulus Therapeutics Inc. | Targeting microRNAs for metabolic disorders |
US20170298352A1 (en) * | 2014-09-30 | 2017-10-19 | Research Institute at Nationwide Children's Hospit al | Compositions and methods for treating hepatic fibrosis |
EP3239297B1 (en) * | 2014-12-27 | 2021-03-10 | Bonac Corporation | Naturally occuring mirna for controlling gene expression, and use of same |
JP2018503646A (ja) | 2015-01-20 | 2018-02-08 | ミラゲン セラピューティクス, インコーポレイテッド | miR−92阻害剤およびその使用 |
GB201504772D0 (en) | 2015-03-20 | 2015-05-06 | Univ Aston | Preeclampsia |
US11142769B2 (en) | 2015-03-27 | 2021-10-12 | Bonac Corporation | Single-stranded nucleic acid molecule having delivery function and gene expression regulating ability |
EP4218771A1 (en) | 2015-03-27 | 2023-08-02 | Yeda Research and Development Co. Ltd | Methods of treating motor neuron diseases |
CA2982146A1 (en) | 2015-04-10 | 2016-10-13 | Spatial Transcriptomics Ab | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
EP3284822A1 (en) * | 2015-04-17 | 2018-02-21 | The University of Tokyo | Therapeutic agent for eye disease |
WO2016183414A1 (en) * | 2015-05-14 | 2016-11-17 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Systems and methods for characterizing granulomatous diseases |
WO2016190899A1 (en) * | 2015-05-23 | 2016-12-01 | Beem Alan M H | Pri-mirna libraries and methods for making and using pri-mirna libraries |
US10858627B2 (en) | 2015-07-30 | 2020-12-08 | Regents Of The University Of Minnesota | Regulation of mesodermal specification |
CN108367017A (zh) * | 2015-08-13 | 2018-08-03 | 索马根尼科斯公司 | 用于伤口愈合的短小发夹rna与微rna的组合物以及方法 |
WO2017032776A1 (en) * | 2015-08-21 | 2017-03-02 | Universitätsklinikum Jena | Human micrornas for treatment of malignant tumours |
US11285168B2 (en) | 2015-09-28 | 2022-03-29 | National University Corporation Chiba University | Method for suppressing tumors by miR-200 family inhibition |
EP3356553A1 (en) | 2015-09-29 | 2018-08-08 | The Research Institute at Nationwide Children's Hospital | Methods for detecting hepatic fibrosis and responsiveness to therapy |
JP6666002B2 (ja) * | 2015-10-07 | 2020-03-13 | 国立大学法人京都大学 | Tdp−43プロテノパシーの予防又は治療用組成物 |
JP2018537983A (ja) * | 2015-12-10 | 2018-12-27 | ウニヴェルズィテート・フューア・ボーデンクルトゥーア・ウィーン | 骨折および骨障害の診断および治療のための組成物および方法 |
EP3181698A1 (en) | 2015-12-16 | 2017-06-21 | European Molecular Biology Laboratory (EMBL) | Microrna mir-142 as stem cell marker |
CA3001536A1 (en) | 2015-12-28 | 2017-07-06 | Riken | Compositions for use in recovering or ameliorating deterioration of physiological functions due to aging |
US10975436B2 (en) | 2016-01-05 | 2021-04-13 | Diamir, Llc | Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders |
CN105543225A (zh) * | 2016-01-07 | 2016-05-04 | 华东师范大学 | miR143及其诱导物LTA在制备抑制痤疮炎症药物中的应用 |
US10771508B2 (en) | 2016-01-19 | 2020-09-08 | Nadejda Sarmova | Systems and methods for establishing a virtual shared experience for media playback |
CA3016592A1 (en) | 2016-03-04 | 2017-09-08 | Rhode Island Hospital | Targeting microrna for cancer treatment |
US11149313B2 (en) | 2016-03-21 | 2021-10-19 | Diamir, Llc | Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases |
CN109477090B (zh) * | 2016-04-14 | 2022-03-22 | e-NA生物科技公司 | 微小rna-143衍生物 |
WO2017192601A1 (en) * | 2016-05-02 | 2017-11-09 | University Of Massachusetts | T cell differentiation and function regulation |
CN109562140B (zh) * | 2016-06-03 | 2023-01-03 | 霍夫耳科研究所 | 用于内耳感觉毛细胞再生/替换的联合疗法 |
EP3533868A4 (en) * | 2016-10-31 | 2019-12-11 | Gifu University | DOUBLE-STRANDED NUCLEIC ACID MOLECULE AND USE THEREOF |
JP7130639B2 (ja) | 2016-11-01 | 2022-09-05 | ザ・リサーチ・ファウンデーション・フォー・ザ・ステイト・ユニヴァーシティ・オブ・ニューヨーク | 5-ハロウラシル修飾マイクロrna及びがんの処置におけるその使用 |
CN107058470B (zh) * | 2016-11-03 | 2020-09-01 | 中国人民解放军陆军军医大学 | 一种通过联合miR-136和miR-4791预测急性高山病发病风险的诊断试剂盒 |
JP2019535839A (ja) | 2016-11-29 | 2019-12-12 | ピュアテック ヘルス エルエルシー | 治療剤の送達のためのエクソソーム |
CN107223203B (zh) | 2017-04-19 | 2018-07-06 | 深圳市汇顶科技股份有限公司 | 光强检测方法、装置及智能终端 |
WO2018199231A1 (ja) * | 2017-04-28 | 2018-11-01 | 一丸ファルコス株式会社 | プラセンタ抽出物 |
WO2018204829A1 (en) * | 2017-05-04 | 2018-11-08 | University Of Maryland, Baltimore | Methods for preventing neural tube defects in diabetic pregnancy |
EP3624825A4 (en) * | 2017-05-19 | 2021-03-10 | Georgia State University Research Foundation, Inc. | RECOMBINANT ONCOLYTIC VIRUS |
US20210139895A1 (en) * | 2017-06-16 | 2021-05-13 | Prostemics Co., Ltd. | Pharmaceutical composition for preventing or treating cancer |
US10781487B2 (en) | 2017-07-24 | 2020-09-22 | Diamir, Llc | miRNA-based methods for detecting and monitoring aging |
WO2019116234A1 (en) | 2017-12-12 | 2019-06-20 | Nestec S.A. | Methods for determining microbiome ribosomal rna composition changes |
KR20200131287A (ko) * | 2018-03-14 | 2020-11-23 | 베스 이스라엘 데코니스 메디칼 센터 | 마이크로-rna 22의 억제제 |
WO2019195765A1 (en) * | 2018-04-06 | 2019-10-10 | University Of Massachusetts | Mlk-regulated micrornas in angiogenesis and tumor development |
US11519033B2 (en) | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
KR102115960B1 (ko) * | 2018-11-28 | 2020-05-27 | 송미연 | 인간 중간엽 줄기세포를 갑상선 호르몬 분비세포로 분화 방법 |
US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US20220145392A1 (en) * | 2019-03-11 | 2022-05-12 | Ochsner Health System | Microrna regulatory network as biomarkers of seizure in patients with spontaneous intracerebral hemorrhage |
KR102248420B1 (ko) * | 2019-03-15 | 2021-05-06 | 주식회사 제너로스 | miR-142-3p의 표적 서열을 포함하는 재조합 벡터 |
US20220251552A1 (en) * | 2019-03-25 | 2022-08-11 | The Trustees Of The University Of Pennsylvania | Regenerative Therapy Based on miRNA-302 Mimics for Enhancing Host Recovery from Pneumonia Caused by Streptococcus pneumoniae |
EP3976820A1 (en) | 2019-05-30 | 2022-04-06 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
US10844380B1 (en) | 2019-06-17 | 2020-11-24 | Biorchestra Co., Ltd. | Uses for prevention or treatment of brain diseases using microrna |
US11198908B2 (en) | 2019-06-17 | 2021-12-14 | Biorchestra Co., Ltd. | Method for diagnosis of Alzheimer's disease using microRNA |
CN110551809A (zh) * | 2019-08-21 | 2019-12-10 | 昆明医科大学第一附属医院 | miR-124在脊髓损伤修复中的用途 |
WO2021091611A1 (en) | 2019-11-08 | 2021-05-14 | 10X Genomics, Inc. | Spatially-tagged analyte capture agents for analyte multiplexing |
WO2021092433A2 (en) | 2019-11-08 | 2021-05-14 | 10X Genomics, Inc. | Enhancing specificity of analyte binding |
US12037585B2 (en) | 2019-12-23 | 2024-07-16 | University Of Massachusetts | Oligonucleotides for tissue specific gene expression modulation |
ES2946357T3 (es) | 2019-12-23 | 2023-07-17 | 10X Genomics Inc | Métodos para el análisis espacial usando ligación con molde de ARN |
US11732299B2 (en) | 2020-01-21 | 2023-08-22 | 10X Genomics, Inc. | Spatial assays with perturbed cells |
US11702693B2 (en) | 2020-01-21 | 2023-07-18 | 10X Genomics, Inc. | Methods for printing cells and generating arrays of barcoded cells |
US11821035B1 (en) | 2020-01-29 | 2023-11-21 | 10X Genomics, Inc. | Compositions and methods of making gene expression libraries |
US12076701B2 (en) | 2020-01-31 | 2024-09-03 | 10X Genomics, Inc. | Capturing oligonucleotides in spatial transcriptomics |
US11898205B2 (en) | 2020-02-03 | 2024-02-13 | 10X Genomics, Inc. | Increasing capture efficiency of spatial assays |
US11732300B2 (en) | 2020-02-05 | 2023-08-22 | 10X Genomics, Inc. | Increasing efficiency of spatial analysis in a biological sample |
US11835462B2 (en) | 2020-02-11 | 2023-12-05 | 10X Genomics, Inc. | Methods and compositions for partitioning a biological sample |
US11891654B2 (en) | 2020-02-24 | 2024-02-06 | 10X Genomics, Inc. | Methods of making gene expression libraries |
US11926863B1 (en) | 2020-02-27 | 2024-03-12 | 10X Genomics, Inc. | Solid state single cell method for analyzing fixed biological cells |
US11768175B1 (en) | 2020-03-04 | 2023-09-26 | 10X Genomics, Inc. | Electrophoretic methods for spatial analysis |
US20230210883A1 (en) * | 2020-03-13 | 2023-07-06 | Duke University | Compositions for the treatment of nash and associated disorders and methods of using same |
CN115916999A (zh) | 2020-04-22 | 2023-04-04 | 10X基因组学有限公司 | 用于使用靶向rna耗竭进行空间分析的方法 |
WO2021237087A1 (en) | 2020-05-22 | 2021-11-25 | 10X Genomics, Inc. | Spatial analysis to detect sequence variants |
EP4414459A3 (en) | 2020-05-22 | 2024-09-18 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
WO2021242834A1 (en) | 2020-05-26 | 2021-12-02 | 10X Genomics, Inc. | Method for resetting an array |
AU2021283184A1 (en) | 2020-06-02 | 2023-01-05 | 10X Genomics, Inc. | Spatial transcriptomics for antigen-receptors |
AU2021283174A1 (en) | 2020-06-02 | 2023-01-05 | 10X Genomics, Inc. | Nucleic acid library methods |
US12031177B1 (en) | 2020-06-04 | 2024-07-09 | 10X Genomics, Inc. | Methods of enhancing spatial resolution of transcripts |
EP4162074B1 (en) | 2020-06-08 | 2024-04-24 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
EP4165207B1 (en) | 2020-06-10 | 2024-09-25 | 10X Genomics, Inc. | Methods for determining a location of an analyte in a biological sample |
EP4172362B1 (en) | 2020-06-25 | 2024-09-18 | 10X Genomics, Inc. | Spatial analysis of dna methylation |
US11981960B1 (en) | 2020-07-06 | 2024-05-14 | 10X Genomics, Inc. | Spatial analysis utilizing degradable hydrogels |
US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
US11981958B1 (en) | 2020-08-20 | 2024-05-14 | 10X Genomics, Inc. | Methods for spatial analysis using DNA capture |
CN112190592B (zh) * | 2020-08-25 | 2022-03-11 | 苏州市立医院(北区) | miRNA在制备防治骨关节炎药物的应用、miRNA高表达的外泌体和应用 |
US11926822B1 (en) | 2020-09-23 | 2024-03-12 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
WO2022076774A2 (en) * | 2020-10-08 | 2022-04-14 | The Trustees Of Columbia University In The City Of New York | Treatment and detection of liver fibrosis and liver disease using microrna |
CN112375823B (zh) * | 2020-10-22 | 2022-09-16 | 上海交通大学医学院附属瑞金医院 | miRNA抑制剂在制备治疗和/或预防淋巴瘤的药物中的应用 |
US11827935B1 (en) | 2020-11-19 | 2023-11-28 | 10X Genomics, Inc. | Methods for spatial analysis using rolling circle amplification and detection probes |
EP4121555A1 (en) | 2020-12-21 | 2023-01-25 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
EP4301870A1 (en) | 2021-03-18 | 2024-01-10 | 10X Genomics, Inc. | Multiplex capture of gene and protein expression from a biological sample |
WO2022256503A1 (en) | 2021-06-03 | 2022-12-08 | 10X Genomics, Inc. | Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis |
WO2022272269A1 (en) * | 2021-06-22 | 2022-12-29 | The Curators Of The University Of Missouri | Multianalyte biomarkers for lung cancer |
WO2023034489A1 (en) | 2021-09-01 | 2023-03-09 | 10X Genomics, Inc. | Methods, compositions, and kits for blocking a capture probe on a spatial array |
WO2023118546A2 (en) | 2021-12-23 | 2023-06-29 | Boehringer Ingelheim International Gmbh | METHODS AND MOLECULES FOR RNA INTERFERENCE (RNAi) |
US11541116B1 (en) | 2022-01-07 | 2023-01-03 | Kojin Therapeutics, Inc. | Methods and compositions for inducing ferroptosis in vivo |
WO2024108031A2 (en) * | 2022-11-16 | 2024-05-23 | University Of Notre Dame Du Lac | Mirna cocktail for treatment and prevention of fibrosis |
KR102583230B1 (ko) * | 2023-03-16 | 2023-09-27 | 재단법인 전남바이오산업진흥원 | 뇌경색 예방 또는 치료용 조성물 |
Family Cites Families (497)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2006A (en) * | 1841-03-16 | Clamp for crimping leather | ||
US2007A (en) * | 1841-03-16 | Improvement in the mode of harvesting grain | ||
US1529202A (en) | 1924-07-16 | 1925-03-10 | Joseph H Miller | Festooning machine for carrying paper and the like |
GB1529202A (en) | 1976-02-20 | 1978-10-18 | Ciba Geigy Ag | Spectral sensitising dyes |
US5583013A (en) | 1977-11-08 | 1996-12-10 | Genentech, Inc. | Method and means for microbial polypeptide expression |
US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
US5221619A (en) | 1977-11-08 | 1993-06-22 | Genentech, Inc. | Method and means for microbial polypeptide expression |
JPS55116259A (en) | 1979-03-01 | 1980-09-06 | Fuji Photo Film Co Ltd | Microimmunoassay method |
JPS5745460A (en) | 1980-09-02 | 1982-03-15 | Fuji Photo Film Co Ltd | Inspection sheet for measuring trace component and inspecting method using said sheet |
EP0047472B1 (en) | 1980-09-02 | 1985-04-24 | Fuji Photo Film Co., Ltd. | Method for immunochemical measurement of trace components |
NL8200523A (nl) | 1982-02-11 | 1983-09-01 | Univ Leiden | Werkwijze voor het in vitro transformeren van planteprotoplasten met plasmide-dna. |
US4849513A (en) | 1983-12-20 | 1989-07-18 | California Institute Of Technology | Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups |
US4828979A (en) | 1984-11-08 | 1989-05-09 | Life Technologies, Inc. | Nucleotide analogs for nucleic acid labeling and detection |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
DE3529478A1 (de) | 1985-08-16 | 1987-02-19 | Boehringer Mannheim Gmbh | 7-desaza-2'desoxyguanosin-nukleotide, verfahren zu deren herstellung und deren verwendung zur nukleinsaeure-sequenzierung |
US4682195A (en) | 1985-09-30 | 1987-07-21 | General Electric Company | Insulated gate device with configured emitter contact pad |
US4959463A (en) | 1985-10-15 | 1990-09-25 | Genentech, Inc. | Intermediates |
US4659774A (en) | 1985-11-01 | 1987-04-21 | American Hoechst Corporation | Support for solid-phase oligonucleotide synthesis |
US5011769A (en) | 1985-12-05 | 1991-04-30 | Meiogenics U.S. Limited Partnership | Methods for detecting nucleic acid sequences |
US4876187A (en) | 1985-12-05 | 1989-10-24 | Meiogenics, Inc. | Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences |
US4910300A (en) | 1985-12-11 | 1990-03-20 | Chiron Corporation | Method for making nucleic acid probes |
CA1284931C (en) | 1986-03-13 | 1991-06-18 | Henry A. Erlich | Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
US5268486A (en) | 1986-04-18 | 1993-12-07 | Carnegie-Mellon Unversity | Method for labeling and detecting materials employing arylsulfonate cyanine dyes |
EP0266032A1 (en) | 1986-08-29 | 1988-05-04 | Beecham Group Plc | Modified fibrinolytic enzyme |
US5202231A (en) | 1987-04-01 | 1993-04-13 | Drmanac Radoje T | Method of sequencing of genomes by hybridization of oligonucleotide probes |
US5525464A (en) | 1987-04-01 | 1996-06-11 | Hyseq, Inc. | Method of sequencing by hybridization of oligonucleotide probes |
US4816571A (en) | 1987-06-04 | 1989-03-28 | Applied Biosystems, Inc. | Chemical capping by phosphitylation during oligonucleotide synthesis |
GB8803000D0 (en) | 1988-02-10 | 1988-03-09 | Ekins Roger Philip | Determination of ambient concentrations of several analytes |
US5824311A (en) | 1987-11-30 | 1998-10-20 | Trustees Of The University Of Pennsylvania | Treatment of tumors with monoclonal antibodies against oncogene antigens |
US4952500A (en) | 1988-02-01 | 1990-08-28 | University Of Georgia Research Foundation, Inc. | Cloning systems for Rhodococcus and related bacteria |
GB8810400D0 (en) | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
US4999290A (en) | 1988-03-31 | 1991-03-12 | The Board Of Regents, The University Of Texas System | Detection of genomic abnormalities with unique aberrant gene transcripts |
US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
US5602244A (en) | 1988-05-26 | 1997-02-11 | Competitive Technologies, Inc. | Polynucleotide phosphorodithioate compounds |
GB8822228D0 (en) | 1988-09-21 | 1988-10-26 | Southern E M | Support-bound oligonucleotides |
US5708154A (en) | 1989-02-24 | 1998-01-13 | City Of Hope | RNA-DNA hybrid molecules of nucleic acid |
US6867195B1 (en) | 1989-03-21 | 2005-03-15 | Vical Incorporated | Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
US5871928A (en) | 1989-06-07 | 1999-02-16 | Fodor; Stephen P. A. | Methods for nucleic acid analysis |
US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5242974A (en) | 1991-11-22 | 1993-09-07 | Affymax Technologies N.V. | Polymer reversal on solid surfaces |
US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5302523A (en) | 1989-06-21 | 1994-04-12 | Zeneca Limited | Transformation of plant cells |
DE3924454A1 (de) | 1989-07-24 | 1991-02-07 | Cornelis P Prof Dr Hollenberg | Die anwendung von dna und dna-technologie fuer die konstruktion von netzwerken zur verwendung in der chip-konstruktion und chip-produktion (dna chips) |
US7705215B1 (en) | 1990-04-17 | 2010-04-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5550318A (en) | 1990-04-17 | 1996-08-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5141813A (en) | 1989-08-28 | 1992-08-25 | Clontech Laboratories, Inc. | Multifunctional controlled pore glass reagent for solid phase oligonucleotide synthesis |
GB8920097D0 (en) | 1989-09-06 | 1989-10-18 | Ici Plc | Amplification processes |
US5545522A (en) | 1989-09-22 | 1996-08-13 | Van Gelder; Russell N. | Process for amplifying a target polynucleotide sequence using a single primer-promoter complex |
US5366860A (en) | 1989-09-29 | 1994-11-22 | Applied Biosystems, Inc. | Spectrally resolvable rhodamine dyes for nucleic acid sequence determination |
US5322783A (en) | 1989-10-17 | 1994-06-21 | Pioneer Hi-Bred International, Inc. | Soybean transformation by microparticle bombardment |
EP0942000B1 (en) | 1989-10-24 | 2004-06-23 | Isis Pharmaceuticals, Inc. | 2'-Modified oligonucleotides |
US5188934A (en) | 1989-11-14 | 1993-02-23 | Applied Biosystems, Inc. | 4,7-dichlorofluorescein dyes as molecular probes |
EP0430881A3 (en) | 1989-11-29 | 1991-10-23 | Ciba-Geigy Ag | Photochromic compounds, process for their preparation and their use |
US5486603A (en) | 1990-01-08 | 1996-01-23 | Gilead Sciences, Inc. | Oligonucleotide having enhanced binding affinity |
US6153737A (en) | 1990-01-11 | 2000-11-28 | Isis Pharmaceuticals, Inc. | Derivatized oligonucleotides having improved uptake and other properties |
US5670633A (en) | 1990-01-11 | 1997-09-23 | Isis Pharmaceuticals, Inc. | Sugar modified oligonucleotides that detect and modulate gene expression |
US5859221A (en) | 1990-01-11 | 1999-01-12 | Isis Pharmaceuticals, Inc. | 2'-modified oligonucleotides |
US5872232A (en) | 1990-01-11 | 1999-02-16 | Isis Pharmaceuticals Inc. | 2'-O-modified oligonucleotides |
US5484956A (en) | 1990-01-22 | 1996-01-16 | Dekalb Genetics Corporation | Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin |
US5214136A (en) | 1990-02-20 | 1993-05-25 | Gilead Sciences, Inc. | Anthraquinone-derivatives oligonucleotides |
US5288644A (en) | 1990-04-04 | 1994-02-22 | The Rockefeller University | Instrument and method for the sequencing of genome |
US5470967A (en) | 1990-04-10 | 1995-11-28 | The Dupont Merck Pharmaceutical Company | Oligonucleotide analogs with sulfamate linkages |
GB9009980D0 (en) | 1990-05-03 | 1990-06-27 | Amersham Int Plc | Phosphoramidite derivatives,their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides |
US5223618A (en) | 1990-08-13 | 1993-06-29 | Isis Pharmaceuticals, Inc. | 4'-desmethyl nucleoside analog compounds |
US5378825A (en) | 1990-07-27 | 1995-01-03 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs |
US5602240A (en) | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
US5623070A (en) | 1990-07-27 | 1997-04-22 | Isis Pharmaceuticals, Inc. | Heteroatomic oligonucleoside linkages |
US5614617A (en) | 1990-07-27 | 1997-03-25 | Isis Pharmaceuticals, Inc. | Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression |
US5610289A (en) | 1990-07-27 | 1997-03-11 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogues |
US5432272A (en) | 1990-10-09 | 1995-07-11 | Benner; Steven A. | Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases |
US5965364A (en) | 1990-10-09 | 1999-10-12 | Benner; Steven Albert | Method for selecting functional deoxyribonucleotide derivatives |
WO1992007095A1 (en) | 1990-10-15 | 1992-04-30 | Stratagene | Arbitrarily primed polymerase chain reaction method for fingerprinting genomes |
US5384253A (en) | 1990-12-28 | 1995-01-24 | Dekalb Genetics Corporation | Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes |
US5672697A (en) | 1991-02-08 | 1997-09-30 | Gilead Sciences, Inc. | Nucleoside 5'-methylene phosphonates |
US6287792B1 (en) | 1991-06-17 | 2001-09-11 | The Regents Of The University Of California | Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology |
AU662906B2 (en) | 1991-06-26 | 1995-09-21 | F. Hoffmann-La Roche Ag | Methods for detection of carcinoma metastases by nucleic acid amplification |
US6369209B1 (en) * | 1999-05-03 | 2002-04-09 | Isis Pharmaceuticals, Inc. | Oligonucleotides having A-DNA form and B-DNA form conformational geometry |
AU2515992A (en) | 1991-08-20 | 1993-03-16 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
US5639603A (en) | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
US5610042A (en) | 1991-10-07 | 1997-03-11 | Ciba-Geigy Corporation | Methods for stable transformation of wheat |
IL103674A0 (en) | 1991-11-19 | 1993-04-04 | Houston Advanced Res Center | Method and apparatus for molecule detection |
US5412087A (en) | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
US5324633A (en) | 1991-11-22 | 1994-06-28 | Affymax Technologies N.V. | Method and apparatus for measuring binding affinity |
US5256555A (en) | 1991-12-20 | 1993-10-26 | Ambion, Inc. | Compositions and methods for increasing the yields of in vitro RNA transcription and other polynucleotide synthetic reactions |
US5700922A (en) | 1991-12-24 | 1997-12-23 | Isis Pharmaceuticals, Inc. | PNA-DNA-PNA chimeric macromolecules |
US5260191A (en) | 1992-01-30 | 1993-11-09 | Agracetus, Inc. | Method for diagnosing tumors |
JPH07504087A (ja) | 1992-02-12 | 1995-05-11 | クロマジェン インク | 蛍光性n−ヌクレオシド及び蛍光性n−ヌクレオシド構造類似体の応用 |
US5652099A (en) | 1992-02-12 | 1997-07-29 | Conrad; Michael J. | Probes comprising fluorescent nucleosides and uses thereof |
DE4204650C1 (zh) | 1992-02-15 | 1993-07-08 | Hoffmeister, Helmut, Dr., 4400 Muenster, De | |
DE69333650T2 (de) | 1992-02-19 | 2006-01-12 | The Public Health Research Institute Of The City Of New York, Inc. | Neue anordnungn von oligonukleotiden und ihr nutzen zum sortieren, isolieren, sequenzieren und manipulieren von nukleinsäuren |
US5262311A (en) | 1992-03-11 | 1993-11-16 | Dana-Farber Cancer Institute, Inc. | Methods to clone polyA mRNA |
DE69332665T2 (de) | 1992-03-11 | 2003-11-27 | Dana-Farber Cancer Institute, Inc. | Methode um mrna zu klonieren |
JP2775346B2 (ja) | 1992-04-03 | 1998-07-16 | アプライド バイオシステムズ,インコーポレイテッド | プローブ構成物および方法 |
GB9208545D0 (en) | 1992-04-21 | 1992-06-03 | Gatsby Charitable Foundation T | Virus resistant plants |
US5428148A (en) | 1992-04-24 | 1995-06-27 | Beckman Instruments, Inc. | N4 - acylated cytidinyl compounds useful in oligonucleotide synthesis |
ATE398679T1 (de) | 1992-07-07 | 2008-07-15 | Japan Tobacco Inc | Verfahren zur transformation einer monokotyledon pflanze |
US5702932A (en) | 1992-07-20 | 1997-12-30 | University Of Florida | Microinjection methods to transform arthropods with exogenous DNA |
HUT70467A (en) | 1992-07-27 | 1995-10-30 | Pioneer Hi Bred Int | An improved method of agrobactenium-mediated transformation of cultvred soyhean cells |
US5438131A (en) | 1992-09-16 | 1995-08-01 | Bergstrom; Donald E. | 3-nitropyrrole nucleoside |
US5554501A (en) | 1992-10-29 | 1996-09-10 | Beckman Instruments, Inc. | Biopolymer synthesis using surface activated biaxially oriented polypropylene |
GB9222888D0 (en) | 1992-10-30 | 1992-12-16 | British Tech Group | Tomography |
US5503980A (en) | 1992-11-06 | 1996-04-02 | Trustees Of Boston University | Positional sequencing by hybridization |
US5858988A (en) | 1993-02-24 | 1999-01-12 | Wang; Jui H. | Poly-substituted-phenyl-oligoribo nucleotides having enhanced stability and membrane permeability and methods of use |
US5801005A (en) | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
US5580726A (en) | 1994-04-29 | 1996-12-03 | Geron Corporation | Method and Kit for enhanced differential display |
US5767259A (en) | 1994-12-27 | 1998-06-16 | Naxcor | Oligonucleotides containing base-free linking groups with photoactivatable side chains |
US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
US5470710A (en) | 1993-10-22 | 1995-11-28 | University Of Utah | Automated hybridization/imaging device for fluorescent multiplex DNA sequencing |
US5472672A (en) | 1993-10-22 | 1995-12-05 | The Board Of Trustees Of The Leland Stanford Junior University | Apparatus and method for polymer synthesis using arrays |
EP0730663B1 (en) | 1993-10-26 | 2003-09-24 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US6045996A (en) | 1993-10-26 | 2000-04-04 | Affymetrix, Inc. | Hybridization assays on oligonucleotide arrays |
US5429807A (en) | 1993-10-28 | 1995-07-04 | Beckman Instruments, Inc. | Method and apparatus for creating biopolymer arrays on a solid support surface |
US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
AU8102694A (en) | 1993-11-17 | 1995-06-06 | Id Biomedical Corporation | Cycling probe cleavage detection of nucleic acid sequences |
US5610287A (en) | 1993-12-06 | 1997-03-11 | Molecular Tool, Inc. | Method for immobilizing nucleic acid molecules |
US5446137B1 (en) | 1993-12-09 | 1998-10-06 | Behringwerke Ag | Oligonucleotides containing 4'-substituted nucleotides |
US5519134A (en) | 1994-01-11 | 1996-05-21 | Isis Pharmaceuticals, Inc. | Pyrrolidine-containing monomers and oligomers |
GB9401833D0 (en) | 1994-02-01 | 1994-03-30 | Isis Innovation | Method for discovering ligands |
JPH09508800A (ja) | 1994-02-14 | 1997-09-09 | スミスクライン・ビーチャム・コーポレイション | 差次的発現遺伝子の同定法 |
DE4406524A1 (de) | 1994-02-28 | 1995-08-31 | Boehringer Mannheim Gmbh | 3'-RNA-Markierung mit Terminaler Transferase |
US6077835A (en) | 1994-03-23 | 2000-06-20 | Case Western Reserve University | Delivery of compacted nucleic acid to cells |
US5844107A (en) | 1994-03-23 | 1998-12-01 | Case Western Reserve University | Compacted nucleic acids and their delivery to cells |
CA2186118C (en) | 1994-03-23 | 2010-10-19 | Richard W. Hanson | Compacted nucleic acids and their delivery to cells |
US5972901A (en) | 1994-03-23 | 1999-10-26 | Case Western Reserve University | Serpin enzyme complex receptor--mediated gene transfer |
US5571639A (en) | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US5656610A (en) | 1994-06-21 | 1997-08-12 | University Of Southern California | Producing a protein in a mammal by injection of a DNA-sequence into the tongue |
US6146886A (en) | 1994-08-19 | 2000-11-14 | Ribozyme Pharmaceuticals, Inc. | RNA polymerase III-based expression of therapeutic RNAs |
GB9506466D0 (en) | 1994-08-26 | 1995-05-17 | Prolifix Ltd | Cell cycle regulated repressor and dna element |
US5574146A (en) | 1994-08-30 | 1996-11-12 | Beckman Instruments, Inc. | Oligonucleotide synthesis with substituted aryl carboxylic acids as activators |
US5554744A (en) | 1994-09-23 | 1996-09-10 | Hybridon, Inc. | Method for loading solid supports for nucleic acid synthesis |
US6096314A (en) | 1994-10-07 | 2000-08-01 | Yeda Research And Development Co. Ltd. | Peptides and pharmaceutical compositions comprising them |
US5604097A (en) | 1994-10-13 | 1997-02-18 | Spectragen, Inc. | Methods for sorting polynucleotides using oligonucleotide tags |
US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
US5830645A (en) | 1994-12-09 | 1998-11-03 | The Regents Of The University Of California | Comparative fluorescence hybridization to nucleic acid arrays |
US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
WO1996029430A1 (en) | 1995-03-17 | 1996-09-26 | John Wayne Cancer Institute | Detection of melanoma or breast metastases with a multiple marker assay |
US5801155A (en) | 1995-04-03 | 1998-09-01 | Epoch Pharmaceuticals, Inc. | Covalently linked oligonucleotide minor grove binder conjugates |
GB9507238D0 (en) | 1995-04-07 | 1995-05-31 | Isis Innovation | Detecting dna sequence variations |
US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
DE19518505A1 (de) | 1995-05-19 | 1996-11-21 | Max Planck Gesellschaft | Verfahren zur Genexpressionsanalyse |
IL122290A0 (en) | 1995-06-07 | 1998-04-05 | Inex Pharmaceuticals Corp | Lipid-nucleic acid complex its preparation and use |
US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US5981501A (en) | 1995-06-07 | 1999-11-09 | Inex Pharmaceuticals Corp. | Methods for encapsulating plasmids in lipid bilayers |
US6111095A (en) | 1995-06-07 | 2000-08-29 | Merck & Co., Inc. | Capped synthetic RNA, analogs, and aptamers |
US6998268B2 (en) | 1995-07-03 | 2006-02-14 | Dainippon Sumitomo Pharma Co. Ltd. | Gene preparations |
US5637683A (en) | 1995-07-13 | 1997-06-10 | Cornell Research Foundation, Inc. | Nucleic acid analog with amide linkage and method of making that analog |
US5661028A (en) | 1995-09-29 | 1997-08-26 | Lockheed Martin Energy Systems, Inc. | Large scale DNA microsequencing device |
US5658734A (en) | 1995-10-17 | 1997-08-19 | International Business Machines Corporation | Process for synthesizing chemical compounds |
US5705629A (en) | 1995-10-20 | 1998-01-06 | Hybridon, Inc. | Methods for H-phosphonate synthesis of mono- and oligonucleotides |
US5871697A (en) | 1995-10-24 | 1999-02-16 | Curagen Corporation | Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing |
US6418382B2 (en) | 1995-10-24 | 2002-07-09 | Curagen Corporation | Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing |
US20040142895A1 (en) | 1995-10-26 | 2004-07-22 | Sirna Therapeutics, Inc. | Nucleic acid-based modulation of gene expression in the vascular endothelial growth factor pathway |
US5780448A (en) | 1995-11-07 | 1998-07-14 | Ottawa Civic Hospital Loeb Research | DNA-based vaccination of fish |
US5998203A (en) * | 1996-04-16 | 1999-12-07 | Ribozyme Pharmaceuticals, Inc. | Enzymatic nucleic acids containing 5'-and/or 3'-cap structures |
EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
JP2002515738A (ja) | 1996-01-23 | 2002-05-28 | アフィメトリックス,インコーポレイティド | 核酸分析法 |
US5837196A (en) | 1996-01-26 | 1998-11-17 | The Regents Of The University Of California | High density array fabrication and readout method for a fiber optic biosensor |
US5670663A (en) | 1996-02-14 | 1997-09-23 | Regents Of The University Of California | Recovery of taxanes from conifers |
US6020481A (en) | 1996-04-01 | 2000-02-01 | The Perkin-Elmer Corporation | Asymmetric benzoxanthene dyes |
US6458530B1 (en) | 1996-04-04 | 2002-10-01 | Affymetrix Inc. | Selecting tag nucleic acids |
JP3898228B2 (ja) | 1996-04-12 | 2007-03-28 | ザ パブリック ヘルス リサーチ インスティチュート オブ ザ シティー オブ ニューヨーク インク | 検出プローブ、キット及びアッセイ |
US5800996A (en) | 1996-05-03 | 1998-09-01 | The Perkin Elmer Corporation | Energy transfer dyes with enchanced fluorescence |
US5863727A (en) | 1996-05-03 | 1999-01-26 | The Perkin-Elmer Corporation | Energy transfer dyes with enhanced fluorescence |
US5945526A (en) | 1996-05-03 | 1999-08-31 | Perkin-Elmer Corporation | Energy transfer dyes with enhanced fluorescence |
US5847162A (en) | 1996-06-27 | 1998-12-08 | The Perkin Elmer Corporation | 4, 7-Dichlororhodamine dyes |
US6184037B1 (en) | 1996-05-17 | 2001-02-06 | Genemedicine, Inc. | Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell |
US5739169A (en) | 1996-05-31 | 1998-04-14 | Procept, Incorporated | Aromatic compounds for inhibiting immune response |
SE506700C2 (sv) | 1996-05-31 | 1998-02-02 | Mikael Kubista | Sond och förfaranden för analys av nukleinsyra |
CA2257109C (en) | 1996-06-04 | 2009-10-06 | University Of Utah Research Foundation | Monitoring hybridization during pcr |
US5898031A (en) | 1996-06-06 | 1999-04-27 | Isis Pharmaceuticals, Inc. | Oligoribonucleotides for cleaving RNA |
US5945100A (en) | 1996-07-31 | 1999-08-31 | Fbp Corporation | Tumor delivery vehicles |
US6770291B2 (en) | 1996-08-30 | 2004-08-03 | The United States Of America As Represented By The Department Of Health And Human Services | Liposome complexes for increased systemic delivery |
GB9618050D0 (en) | 1996-08-29 | 1996-10-09 | Cancer Res Campaign Tech | Global amplification of nucleic acids |
US5981274A (en) | 1996-09-18 | 1999-11-09 | Tyrrell; D. Lorne J. | Recombinant hepatitis virus vectors |
US5886165A (en) | 1996-09-24 | 1999-03-23 | Hybridon, Inc. | Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments |
ATE438719T1 (de) | 1997-03-07 | 2009-08-15 | Siemens Healthcare Diagnostics | Spezifischer marker für prostatakrebs |
CA2254785A1 (en) | 1997-03-10 | 1998-09-17 | Japan Tobacco Inc. | Antisense base sequences |
US6251666B1 (en) | 1997-03-31 | 2001-06-26 | Ribozyme Pharmaceuticals, Inc. | Nucleic acid catalysts comprising L-nucleotide analogs |
US6090556A (en) | 1997-04-07 | 2000-07-18 | Japan Science & Technology Corporation | Method for quantitatively determining the expression of a gene |
NO972006D0 (no) | 1997-04-30 | 1997-04-30 | Forskningsparken I Aas As | Ny metode for diagnose av sykdommer |
WO1998051278A2 (en) | 1997-05-14 | 1998-11-19 | Inex Pharmaceuticals Corporation | High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
US6262252B1 (en) | 1997-05-19 | 2001-07-17 | Mirus, Inc. | Single-step method for labeling nucleic acids with mustard or aziridine labeling reagents |
US5919626A (en) | 1997-06-06 | 1999-07-06 | Orchid Bio Computer, Inc. | Attachment of unmodified nucleic acids to silanized solid phase surfaces |
ATE319856T1 (de) | 1997-06-13 | 2006-03-15 | Affymetrix Inc A Delaware Corp | Verfahren zur erkennung von genpolymorphismen und allelexpression unter verwendung von sondenchips |
US6008379A (en) | 1997-10-01 | 1999-12-28 | The Perkin-Elmer Corporation | Aromatic-substituted xanthene dyes |
US5994624A (en) | 1997-10-20 | 1999-11-30 | Cotton Incorporated | In planta method for the production of transgenic plants |
US6485901B1 (en) | 1997-10-27 | 2002-11-26 | Boston Probes, Inc. | Methods, kits and compositions pertaining to linear beacons |
US6355421B1 (en) | 1997-10-27 | 2002-03-12 | Boston Probes, Inc. | Methods, kits and compositions pertaining to PNA molecular beacons |
WO1999023256A1 (en) | 1997-10-30 | 1999-05-14 | Cold Spring Harbor Laboratory | Probe arrays and methods of using probe arrays for distinguishing dna |
US5936087A (en) | 1997-11-25 | 1999-08-10 | The Perkin-Elmer Corporation | Dibenzorhodamine dyes |
US6238869B1 (en) | 1997-12-19 | 2001-05-29 | High Throughput Genomics, Inc. | High throughput assay system |
US6232066B1 (en) | 1997-12-19 | 2001-05-15 | Neogen, Inc. | High throughput assay system |
US6458533B1 (en) | 1997-12-19 | 2002-10-01 | High Throughput Genomics, Inc. | High throughput assay system for monitoring ESTs |
US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
US6121058A (en) | 1998-01-02 | 2000-09-19 | Intel Corporation | Method for removing accumulated solder from probe card probing features |
US6087102A (en) | 1998-01-07 | 2000-07-11 | Clontech Laboratories, Inc. | Polymeric arrays and methods for their use in binding assays |
US6269846B1 (en) | 1998-01-13 | 2001-08-07 | Genetic Microsystems, Inc. | Depositing fluid specimens on substrates, resulting ordered arrays, techniques for deposition of arrays |
US5942398A (en) | 1998-02-26 | 1999-08-24 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding glutx and uses thereof |
AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
US6004755A (en) | 1998-04-07 | 1999-12-21 | Incyte Pharmaceuticals, Inc. | Quantitative microarray hybridizaton assays |
EP1071753A2 (en) | 1998-04-20 | 2001-01-31 | Ribozyme Pharmaceuticals, Inc. | Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
US6037129A (en) | 1998-05-28 | 2000-03-14 | Medical University Of South Carolina | Multi-marker RT-PCR panel for detecting metastatic breast cancer |
FR2780059B1 (fr) | 1998-06-17 | 2002-10-11 | Bio Merieux | Procede de marquage d'un acide ribonucleique et fragments d'arn marques ainsi obtenus |
US6576420B1 (en) | 1998-06-23 | 2003-06-10 | Regents Of The University Of California | Method for early diagnosis of, and determination of prognosis in, cancer |
GB9815799D0 (en) | 1998-07-21 | 1998-09-16 | Pharmagene Lab Limited | Quantitative analysis of gene expression |
US6730477B1 (en) | 1998-08-04 | 2004-05-04 | Diadexus, Inc. | Method of diagnosing, monitoring and staging breast cancer |
US6140054A (en) | 1998-09-30 | 2000-10-31 | University Of Utah Research Foundation | Multiplex genotyping using fluorescent hybridization probes |
DE69929542T2 (de) | 1998-10-27 | 2006-09-14 | Affymetrix, Inc., Santa Clara | Komplexitätsmanagement und analyse genomischer dna |
DE19956568A1 (de) | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
GB9904991D0 (en) | 1999-03-05 | 1999-04-28 | Univ Nottingham | Genetic screening |
EP1161439B1 (en) | 1999-03-18 | 2010-04-21 | Exiqon A/S | Xylo-lna analogues |
US6383752B1 (en) | 1999-03-31 | 2002-05-07 | Hybridon, Inc. | Pseudo-cyclic oligonucleobases |
US6103576A (en) * | 1999-04-13 | 2000-08-15 | Microchip Technology Incorporated | Dielectric layer of a memory cell having a stacked oxide sidewall and method of fabricating same |
ES2283298T3 (es) | 1999-05-04 | 2007-11-01 | Santaris Pharma A/S | Analogos de l-ribo-lna. |
US6638717B2 (en) | 1999-05-19 | 2003-10-28 | Aventis Pharmaceuticals, Inc. | Microarray-based subtractive hybridzation |
CA2371922C (en) | 1999-05-24 | 2012-03-27 | Introgen Therapeutics, Inc. | Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
US6132997A (en) | 1999-05-28 | 2000-10-17 | Agilent Technologies | Method for linear mRNA amplification |
CA2377385A1 (en) | 1999-06-03 | 2000-12-14 | Jessie L.S. Au | Methods and compositions for modulating cell proliferation and cell death |
WO2000075356A1 (en) | 1999-06-04 | 2000-12-14 | Lin Shi Lung | Rna polymerase chain reaction |
US6964847B1 (en) | 1999-07-14 | 2005-11-15 | Packard Biosciences Company | Derivative nucleic acids and uses thereof |
US6201112B1 (en) | 1999-07-22 | 2001-03-13 | Agilent Technologies Inc. | Method for 3′ end-labeling ribonucleic acids |
US7005261B1 (en) | 1999-07-29 | 2006-02-28 | British Biocell International Limited | Method for detecting nucleic acid target sequences involving in vitro transcription from an RNA polymerase promoter |
US6140500A (en) | 1999-09-03 | 2000-10-31 | Pe Corporation | Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use |
US6511832B1 (en) | 1999-10-06 | 2003-01-28 | Texas A&M University System | In vitro synthesis of capped and polyadenylated mRNAs using baculovirus RNA polymerase |
US20020094546A1 (en) | 1999-10-07 | 2002-07-18 | Shimkets Richard A. | Growth factor polypeptides and nucleic acids encoding same |
WO2001029058A1 (en) | 1999-10-15 | 2001-04-26 | University Of Massachusetts | Rna interference pathway genes as tools for targeted genetic interference |
US6528254B1 (en) | 1999-10-29 | 2003-03-04 | Stratagene | Methods for detection of a target nucleic acid sequence |
US6191278B1 (en) | 1999-11-03 | 2001-02-20 | Pe Corporation | Water-soluble rhodamine dyes and conjugates thereof |
US6458382B1 (en) | 1999-11-12 | 2002-10-01 | Mirus Corporation | Nucleic acid transfer complexes |
US6435245B1 (en) | 1999-11-18 | 2002-08-20 | Pitney Bowes Inc. | System for folding and tabbing sheets |
GB9927444D0 (en) | 1999-11-19 | 2000-01-19 | Cancer Res Campaign Tech | Inhibiting gene expression |
DE10160151A1 (de) | 2001-01-09 | 2003-06-26 | Ribopharma Ag | Verfahren zur Hemmung der Expression eines vorgegebenen Zielgens |
DE10100586C1 (de) | 2001-01-09 | 2002-04-11 | Ribopharma Ag | Verfahren zur Hemmung der Expression eines Ziegens |
WO2001038580A2 (en) | 1999-11-26 | 2001-05-31 | Curagen Corporation | Nucleic acid probe arrays |
US6383749B2 (en) | 1999-12-02 | 2002-05-07 | Clontech Laboratories, Inc. | Methods of labeling nucleic acids for use in array based hybridization assays |
US7205105B2 (en) | 1999-12-08 | 2007-04-17 | Epoch Biosciences, Inc. | Real-time linear detection probes: sensitive 5′-minor groove binder-containing probes for PCR analysis |
EP1257664A4 (en) | 2000-01-28 | 2006-04-05 | Althea Technologies Inc | METHOD FOR THE ANALYSIS OF GENE EXPRESSION |
WO2002081628A2 (en) | 2001-04-05 | 2002-10-17 | Ribozyme Pharmaceuticals, Incorporated | Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies |
US8202979B2 (en) * | 2002-02-20 | 2012-06-19 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
US6447723B1 (en) | 2000-03-13 | 2002-09-10 | Packard Instrument Company, Inc. | Microarray spotting instruments incorporating sensors and methods of using sensors for improving performance of microarray spotting instruments |
US20030084471A1 (en) | 2000-03-16 | 2003-05-01 | David Beach | Methods and compositions for RNA interference |
US20020037540A1 (en) | 2000-03-23 | 2002-03-28 | Shujath Ali | Compositions and methods of diagnosing, monitoring, staging, imaging and treating prostate cancer |
EP1268818A2 (en) | 2000-03-24 | 2003-01-02 | Millennium Pharmaceuticals, Inc. | 18221, dual specificity phosphatase and uses thereof |
US6787335B2 (en) | 2000-03-27 | 2004-09-07 | Diadexus, Inc. | Compositions and methods of diagnosing, monitoring, staging, imaging and treating mammary gland cancer |
AU2001251013A1 (en) | 2000-03-28 | 2001-10-08 | Diadexus, Inc. | Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer |
AU2001251084A1 (en) | 2000-03-29 | 2001-10-08 | Diadexus, Inc. | Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer |
US20020068307A1 (en) | 2000-03-30 | 2002-06-06 | Jason Pluta | Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer |
AU2001249622B2 (en) | 2000-03-30 | 2007-06-07 | Massachusetts Institute Of Technology | RNA sequence-specific mediators of RNA interference |
US6573048B1 (en) | 2000-04-18 | 2003-06-03 | Naxcor | Degradable nucleic acid probes and nucleic acid detection methods |
EP1366366B1 (en) | 2000-05-10 | 2010-10-20 | Signe BioPharma Inc. | Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers |
US20020042388A1 (en) | 2001-05-01 | 2002-04-11 | Cooper Mark J. | Lyophilizable and enhanced compacted nucleic acids |
EP1289565B1 (en) | 2000-06-02 | 2015-04-22 | Bracco Suisse SA | Compounds for targeting endothelial cells |
AU2001270164A1 (en) | 2000-06-26 | 2002-01-08 | The United States Of America As Represented By The Secretary Of Agriculture | Production of vaccines using transgenic plants |
AU2001289617A1 (en) | 2000-06-30 | 2002-01-08 | Epigenomics Ag | Diagnosis of diseases associated with signal transduction |
US6596490B2 (en) | 2000-07-14 | 2003-07-22 | Applied Gene Technologies, Inc. | Nucleic acid hairpin probes and uses thereof |
WO2002010169A1 (en) | 2000-07-31 | 2002-02-07 | F. Hoffmann-La Roche Ag | Piperazine derivatives |
US6797471B2 (en) | 2000-08-04 | 2004-09-28 | Board Of Regents, The University Of Texas System | Detection and diagnosis of smoking related cancers |
JP2002067789A (ja) * | 2000-09-05 | 2002-03-08 | Yazaki Corp | ランプユニットの電線接続構造 |
US20030031678A1 (en) | 2000-09-19 | 2003-02-13 | Shujath Ali | Compositions and methods relating to prostate specific genes and proteins |
US20030082604A1 (en) | 2000-09-27 | 2003-05-01 | Swanson Melvin J. | High density arrays |
US6617112B2 (en) | 2000-10-11 | 2003-09-09 | Monsanto Technology Llc | Methods for gene array analysis of nuclear runoff transcripts |
US7162371B1 (en) | 2000-10-11 | 2007-01-09 | Georgia Tech Research Corporation | Differentially-expressed conifer cDNAs, and their use in improving somatic embryogenesis |
US6350580B1 (en) | 2000-10-11 | 2002-02-26 | Stratagene | Methods for detection of a target nucleic acid using a probe comprising secondary structure |
WO2002032396A2 (en) | 2000-10-16 | 2002-04-25 | Massachusetts Institute Of Technology | Lipid-protein-sugar particles for delivery of nucleic acids |
WO2002048168A1 (en) * | 2000-10-24 | 2002-06-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of tnfr1 expression |
US7001724B1 (en) | 2000-11-28 | 2006-02-21 | Applera Corporation | Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases |
GB0029360D0 (en) | 2000-12-01 | 2001-01-17 | Univ Nottingham | Humanised antibodies and uses thereof |
WO2002044321A2 (en) | 2000-12-01 | 2002-06-06 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Rna interference mediating small rna molecules |
ES2445748T3 (es) | 2000-12-04 | 2014-03-05 | Primagen B.V. | Ensayos basados en ácidos nucleicos de orgánulos celulares endosimbiontes |
US20030099976A1 (en) | 2001-01-17 | 2003-05-29 | Tai-Jay Chang | Androgen receptor complex-associated protein |
US20040115671A1 (en) | 2001-01-18 | 2004-06-17 | Zlokovic Berislav V | Gene expression profiling of endothelium in alzheimer's disease |
US7015047B2 (en) | 2001-01-26 | 2006-03-21 | Aviva Biosciences Corporation | Microdevices having a preferential axis of magnetization and uses thereof |
WO2002064835A2 (en) | 2001-01-31 | 2002-08-22 | Ambion, Inc. | Methods for nucleic acid fingerprint analysis |
US20040110191A1 (en) | 2001-01-31 | 2004-06-10 | Winkler Matthew M. | Comparative analysis of nucleic acids using population tagging |
US20040058373A1 (en) | 2001-01-31 | 2004-03-25 | Winkler Matthew M. | Competitive amplification of fractionated targets from multiple nucleic acid samples |
WO2002073504A1 (en) | 2001-03-14 | 2002-09-19 | Gene Logic, Inc. | A system and method for retrieving and using gene expression data from multiple sources |
US20030170623A1 (en) | 2001-04-13 | 2003-09-11 | Jingwen Chen | Multiplexed gene analysis on a mobile solid support |
EP1390387A4 (en) | 2001-04-20 | 2004-12-08 | Ludwig Inst Cancer Res | CANCER AND TESTICLE ANTIGENS |
US20050065333A1 (en) | 2001-04-27 | 2005-03-24 | Arun Seth | Breast cancer-associated genes and uses thereof |
CA2445947A1 (en) | 2001-04-30 | 2002-11-07 | Targeted Genetics Corporation | Lipid-comprising drug delivery complexes and methods for their production |
AUPR480901A0 (en) | 2001-05-04 | 2001-05-31 | Genomics Research Partners Pty Ltd | Diagnostic method for assessing a condition of a performance animal |
US20040209832A1 (en) | 2001-11-30 | 2004-10-21 | Mcswiggen James | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
US20040243362A1 (en) | 2001-06-01 | 2004-12-02 | Liebman Michael N. | Information processing method for disease stratification and assessment of disease progressing |
US7171311B2 (en) | 2001-06-18 | 2007-01-30 | Rosetta Inpharmatics Llc | Methods of assigning treatment to breast cancer patients |
US20040086504A1 (en) | 2001-06-21 | 2004-05-06 | Deepak Sampath | Cyr61 as a target for treatment and diagnosis of breast cancer |
WO2003001335A2 (en) | 2001-06-22 | 2003-01-03 | Gene Logic, Inc. | Platform for management and mining of genomic data |
AU2002346008A1 (en) | 2001-06-28 | 2003-03-03 | Dermtech International | Method for detection of melanoma |
EP1406653A4 (en) | 2001-06-29 | 2005-05-04 | Univ Leland Stanford Junior | T-LYMPHOCYTE REGULATORY GENES AND METHODS OF USE |
US20030143571A1 (en) | 2001-08-08 | 2003-07-31 | North Carolina State University | Infectious disease microarray |
AU2002331777A1 (en) | 2001-08-30 | 2003-03-18 | Spectral Genomics, Inc. | Arrays comprising pre-labeled biological molecules and methods for making and using these arrays |
US20030198627A1 (en) * | 2001-09-01 | 2003-10-23 | Gert-Jan Arts | siRNA knockout assay method and constructs |
US7078180B2 (en) | 2001-09-05 | 2006-07-18 | The Children's Hospital Of Philadelphia | Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors |
EP1423542A2 (en) | 2001-09-06 | 2004-06-02 | MERCK PATENT GmbH | Genetic analysis of biological samples in arrayed expanded representations of their nucleic acids |
EP1425090A2 (en) | 2001-09-07 | 2004-06-09 | Corning Incorporated | MICROCOLUMN−PLATFORM BASED ARRAY FOR HIGH−THROUGHPUT ANALYSIS |
AU2002341752B2 (en) | 2001-09-19 | 2008-04-03 | Alexion Pharmaceuticals, Inc. | Engineered templates and their use in single primer amplification |
AU2002305767B2 (en) | 2001-09-20 | 2008-04-10 | Cornell Research Foundation, Inc. | Methods and compositions for treating and preventing skin disorders using binding agents specific for PSMA |
US6593091B2 (en) | 2001-09-24 | 2003-07-15 | Beckman Coulter, Inc. | Oligonucleotide probes for detecting nucleic acids through changes in flourescence resonance energy transfer |
EP2385123B1 (en) | 2001-09-28 | 2018-04-25 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Microrna molecules |
EP1434883A2 (en) | 2001-10-02 | 2004-07-07 | Azign Bioscience A/S | Specific differential display arrays |
CA2463725A1 (en) | 2001-10-12 | 2003-11-06 | Spectral Genomics, Inc. | Compilations of nucleic acids and arrays and methods of using them |
WO2003040410A1 (en) | 2001-11-02 | 2003-05-15 | Nimblegen Systems, Inc. | Detection of hybridization oligonucleotide microarray through covalently labeling microarray probe |
US20040063654A1 (en) | 2001-11-02 | 2004-04-01 | Davis Mark E. | Methods and compositions for therapeutic use of RNA interference |
IL161733A0 (en) | 2001-11-02 | 2005-11-20 | Insert Therapeutics Inc | Methods and compositions for therapeutic use of rna interference |
US20050095646A1 (en) | 2001-11-19 | 2005-05-05 | Sherman Michael I. | Method of using a non-antibody protein to detect and measure an analyte |
DE60228995D1 (de) | 2001-12-19 | 2008-10-30 | Affymetrix Inc | Arrayplatten und verfahren zur herstellung von arrayplatten |
CA2469480A1 (en) | 2001-12-27 | 2003-07-17 | Agy Therapeutics, Inc. | Use of biomolecular targets in the treatment and visualization of tumors |
US7141372B2 (en) | 2002-01-18 | 2006-11-28 | Health Research Incorporated | Universal RT-coupled PCR method for the specific amplification of mRNA |
EP1470255A2 (en) | 2002-01-30 | 2004-10-27 | Epigenomics AG | Identification of cell differentiation states based on methylation patterns |
CA2474530A1 (en) | 2002-02-07 | 2003-08-14 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Diagnostic microarray and method of use thereof |
US20030232356A1 (en) | 2002-02-08 | 2003-12-18 | Dooley Thomas P. | Skin cell biomarkers and methods for identifying biomarkers using nucleic acid microarrays |
EP1448590A4 (en) * | 2002-02-20 | 2004-12-15 | Sirna Therapeutics Inc | INHIBITION INDUCED BY THE INTERFERENCE OF RNA OF THE MYC AND MYB GENES OR OF GENES INTERVENING IN THEIR RESPECTIVE PATHWAYS |
WO2003076928A1 (en) | 2002-03-07 | 2003-09-18 | University Of Utah Research Foundation | Methods for identifying large subsets of differentially expressed genes based on multivariate microarray data analysis |
JP2005521420A (ja) | 2002-04-03 | 2005-07-21 | エージーワイ セラピューティクス インコーポレイティッド | 脳腫瘍の処置及び可視化における生体分子標的の使用法 |
US20070025997A1 (en) | 2002-04-03 | 2007-02-01 | Usha Nagavarapu | Use of biomolecular targets in the treatment and visualization of brain tumors |
ES2465574T3 (es) | 2002-05-03 | 2014-06-06 | Duke University | Un método para regular la expresión génica |
DE60323625D1 (de) | 2002-05-03 | 2008-10-30 | Vialogy Llc | Verfahren zur charakterisierung der ausgangssignale eines microarrays |
KR20050037991A (ko) | 2002-05-20 | 2005-04-25 | 노드롭 그루만 코포레이션 | 자동 오염원 생물학적 병원체 검출시스템 |
JP4544989B2 (ja) | 2002-05-24 | 2010-09-15 | ニンブルゲン システムズ インコーポレイテッド | 単一マイクロアレイ上で多数の試料のハイブリダイゼーション反応を行うマイクロアレイ及びその方法 |
AUPS261402A0 (en) | 2002-05-28 | 2002-06-20 | Compusign Pty Ltd | Array monitoring |
US20030228579A1 (en) | 2002-06-05 | 2003-12-11 | Uri Alon | Ordering genes by analysis of expression kinetics |
EP1527176B2 (en) | 2002-08-05 | 2017-03-22 | Silence Therapeutics GmbH | Further novel forms of interfering rna molecules |
WO2004014933A1 (en) * | 2002-08-07 | 2004-02-19 | University Of Massachusetts | Compositions for rna interference and methods of use thereof |
US20040029128A1 (en) | 2002-08-08 | 2004-02-12 | Epigenomics, Inc. | Methods and nucleic acids for the analysis of CpG dinucleotide methylation status associated with the calcitonin gene |
US20040029121A1 (en) | 2002-08-08 | 2004-02-12 | Susan Cottrell | Methods and nucleic acids for the analysis of CpG dinucleotide methylation status associated with the calcitonin gene |
AU2003268105B2 (en) | 2002-08-16 | 2011-11-03 | John Wayne Cancer Institute | Molecular lymphatic mapping of sentinel lymph nodes |
WO2004025556A2 (en) | 2002-09-12 | 2004-03-25 | Baylor College Of Medecine | System and method for image segmentation |
AU2003267583A1 (en) | 2002-09-19 | 2004-04-08 | The Chancellor, Master And Scholars Of The University Of Oxford | Molecular arrays and single molecule detection |
AU2003282877B9 (en) | 2002-09-25 | 2011-05-12 | University Of Massachusetts | In Vivo gene silencing by chemically modified and stable siRNA |
AU2003291287A1 (en) | 2002-11-01 | 2004-06-07 | John Fonda Crary | Apkc isoforms in nervous system disorders and cancer |
EP1418241A1 (en) | 2002-11-08 | 2004-05-12 | PrimaGen Holding B.V. | Method for quantifying a ratio between at least two nucleic acid sequences |
ATE546528T1 (de) | 2002-11-13 | 2012-03-15 | Univ Jefferson | Zusammensetzungen und verfahren zur diagnose und behandlung von krebs |
US7655785B1 (en) | 2002-11-14 | 2010-02-02 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof |
US7250496B2 (en) * | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
US20040175732A1 (en) * | 2002-11-15 | 2004-09-09 | Rana Tariq M. | Identification of micrornas and their targets |
AU2003295539A1 (en) | 2002-11-15 | 2004-06-15 | University Of Massachusetts | Allele-targeted rna interference |
WO2004050125A1 (ja) | 2002-12-03 | 2004-06-17 | Koken Co.,Ltd. | 腫瘍細胞の増殖及び/又は浸潤の抑制剤 |
US7851150B2 (en) | 2002-12-18 | 2010-12-14 | Third Wave Technologies, Inc. | Detection of small nucleic acids |
JP4230457B2 (ja) * | 2002-12-18 | 2009-02-25 | サード・ウェーブ・テクノロジーズ・インク | 低分子核酸の検出方法 |
CN101061236A (zh) | 2003-01-13 | 2007-10-24 | 艾默瑞大学 | 在正常细胞和癌细胞中检测基因表达的方法 |
CN1761756B (zh) | 2003-01-16 | 2013-03-13 | 北卡罗来纳州大学 | 禽类物种中内源性原生殖细胞的耗减 |
WO2004066183A2 (en) * | 2003-01-22 | 2004-08-05 | European Molecular Biology Laboratory | Microrna |
US20040147027A1 (en) | 2003-01-28 | 2004-07-29 | Troy Carol M. | Complex for facilitating delivery of dsRNA into a cell and uses thereof |
US20060247193A1 (en) | 2003-02-10 | 2006-11-02 | National Institute Of Advanced Industrial Science And Technology | Regulation of gene expression by dna interference |
US7816337B2 (en) | 2003-02-18 | 2010-10-19 | Roche Madison Inc. | Reversible attachment of a membrane active polymer to a polynucleotide |
US20040224337A1 (en) | 2003-03-04 | 2004-11-11 | Erik Foehr | Use of biomolecular targets in the treatment and visualization of tumors |
US20050164212A1 (en) * | 2003-03-06 | 2005-07-28 | Todd Hauser | Modulation of gene expression using DNA-RNA hybrids |
US20050112604A1 (en) | 2003-03-14 | 2005-05-26 | Akihide Fujimoto | Loss of heterozygosity of the DNA markers in the 12q22-23 region |
US7718364B2 (en) | 2003-03-25 | 2010-05-18 | John Wayne Cancer Institute | DNA markers for management of cancer |
WO2004090105A2 (en) * | 2003-04-02 | 2004-10-21 | Dharmacon, Inc. | Modified polynucleotides for use in rna interference |
US20040198640A1 (en) | 2003-04-02 | 2004-10-07 | Dharmacon, Inc. | Stabilized polynucleotides for use in RNA interference |
AU2004227414A1 (en) * | 2003-04-03 | 2004-10-21 | Alnylam Pharmaceuticals | iRNA conjugates |
US20040229211A1 (en) | 2003-05-13 | 2004-11-18 | Yeung Wah Hin Alex | Sensitive diagnostic testing methodology using multiplex real time PCR with one dye (MOD) and its use as in severe acute respiratory syndrome (SARS) |
WO2004105573A2 (en) | 2003-05-21 | 2004-12-09 | The Wistar Institute Of Anatomy And Biology | Method of diagnosis of cancer based on gene expression profiles in cells |
ATE485394T1 (de) | 2003-06-02 | 2010-11-15 | Univ Massachusetts | Verfahren und zusammensetzungen zur verbesserung der wirksamkeit und spezifität von fnai |
EP3502252B1 (en) | 2003-06-02 | 2023-04-05 | University of Massachusetts | Methods and compositions for controlling efficacy of rna silencing |
US7750144B2 (en) | 2003-06-02 | 2010-07-06 | University Of Massachusetts | Methods and compositions for enhancing the efficacy and specificity of RNA silencing |
US20050059024A1 (en) | 2003-07-25 | 2005-03-17 | Ambion, Inc. | Methods and compositions for isolating small RNA molecules |
CA2533701A1 (en) * | 2003-07-31 | 2005-02-17 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
US8106180B2 (en) * | 2003-08-07 | 2012-01-31 | Whitehead Institute For Biomedical Research | Methods and products for expression of micro RNAs |
US20050037362A1 (en) | 2003-08-11 | 2005-02-17 | Eppendorf Array Technologies, S.A. | Detection and quantification of siRNA on microarrays |
US20060183128A1 (en) | 2003-08-12 | 2006-08-17 | Epigenomics Ag | Methods and compositions for differentiating tissues for cell types using epigenetic markers |
WO2005017145A1 (ja) | 2003-08-13 | 2005-02-24 | Japan Biological Informatics Consortium | 機能性rnaが制御する被制御遺伝子の同定・予測方法及びその利用方法 |
EA009376B1 (ru) | 2003-11-10 | 2007-12-28 | Нокссон Фарма Аг | Нуклеиновые кислоты, специфично связывающие биоактивный грелин |
US20050130170A1 (en) | 2003-12-16 | 2005-06-16 | Jeanne Harvey | Identification and verification of methylation marker sequences |
US20050130172A1 (en) | 2003-12-16 | 2005-06-16 | Bayer Corporation | Identification and verification of methylation marker sequences |
EP2295604B1 (en) | 2004-02-09 | 2015-04-08 | Thomas Jefferson University | Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features |
US20050182005A1 (en) | 2004-02-13 | 2005-08-18 | Tuschl Thomas H. | Anti-microRNA oligonucleotide molecules |
CA2556435C (en) * | 2004-02-13 | 2014-08-12 | The Rockefeller University | Anti-microrna oligonucleotide molecules |
KR100522307B1 (ko) * | 2004-02-19 | 2005-10-19 | 변영철 | 화장용브러시 |
US7402389B2 (en) | 2004-02-24 | 2008-07-22 | The Translational Genomics Research Institute (Tgen) | Compositions and methods for prognosis of cancers |
US20060195266A1 (en) | 2005-02-25 | 2006-08-31 | Yeatman Timothy J | Methods for predicting cancer outcome and gene signatures for use therein |
JP2007530679A (ja) | 2004-03-27 | 2007-11-01 | ジ・アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティー・オブ・アリゾナ | 癌治療のための組成物および方法 |
US20060134639A1 (en) | 2004-04-06 | 2006-06-22 | Huffel Christophe V | Method for the determination of cellular transcriptional regulation |
US7365058B2 (en) * | 2004-04-13 | 2008-04-29 | The Rockefeller University | MicroRNA and methods for inhibiting same |
CN101056991A (zh) | 2004-04-20 | 2007-10-17 | 基因耐克生物医学制品有限公司 | 检测ncRNA的方法 |
EP1747023B2 (en) | 2004-05-04 | 2016-03-09 | The Board of Trustees of The Leland Stanford Junior University | Methods and compositions for reducing hcv viral genome amounts in a target cell |
AU2005243410B2 (en) | 2004-05-14 | 2010-04-22 | Rosetta Genomics Ltd. | Micronas and uses thereof |
WO2005116261A2 (en) | 2004-05-24 | 2005-12-08 | Albert Einstein College Of Medecine Of Yeshiva University | Rna expression microarrays |
JP5435864B2 (ja) | 2004-05-28 | 2014-03-05 | アシュラジェン インコーポレイテッド | マイクロrnaに関与する方法および組成物 |
US7575863B2 (en) | 2004-05-28 | 2009-08-18 | Applied Biosystems, Llc | Methods, compositions, and kits comprising linker probes for quantifying polynucleotides |
US20050287539A1 (en) | 2004-06-29 | 2005-12-29 | Emmanuel Labourier | Methods and compositions for preparing capped RNA |
US7579451B2 (en) | 2004-07-21 | 2009-08-25 | Alnylam Pharmaceuticals, Inc. | Oligonucleotides comprising a modified or non-natural nucleobase |
JP5192234B2 (ja) | 2004-08-10 | 2013-05-08 | アルナイラム ファーマシューティカルズ, インコーポレイテッド | 化学修飾オリゴヌクレオチド |
JP2008511678A (ja) | 2004-09-02 | 2008-04-17 | イェール ユニバーシティ | マイクロrnaによるオンコジーンの調節 |
US20060057595A1 (en) | 2004-09-16 | 2006-03-16 | Applera Corporation | Compositions, methods, and kits for identifying and quantitating small RNA molecules |
US7825229B2 (en) | 2005-03-25 | 2010-11-02 | Rosetta Genomics Ltd. | Lung cancer-related nucleic acids |
US7592441B2 (en) | 2004-10-04 | 2009-09-22 | Rosetta Genomics Ltd | Liver cancer-related nucleic acids |
US20090186353A1 (en) | 2004-10-04 | 2009-07-23 | Rosetta Genomics Ltd. | Cancer-related nucleic acids |
US7642348B2 (en) | 2004-10-04 | 2010-01-05 | Rosetta Genomics Ltd | Prostate cancer-related nucleic acids |
US20060078894A1 (en) | 2004-10-12 | 2006-04-13 | Winkler Matthew M | Methods and compositions for analyzing nucleic acids |
EP1812596A4 (en) | 2004-10-12 | 2010-07-14 | Wayne John Cancer Inst | TREATMENT OF CANCER AND COMPOSITIONS |
FR2877350B1 (fr) | 2004-11-03 | 2010-08-27 | Centre Nat Rech Scient | IDENTIFICATION ET UTILISATION DE miRNAs IMPLIQUES DANS LA DIFFERENCIATION DE CELLULES ISSUES D'UNE LEUCEMIE MYELOIDE |
DK2302055T3 (da) | 2004-11-12 | 2014-10-13 | Asuragen Inc | Fremgangsmåder og sammensætninger involverende miRNA og miRNA-inhibitormolekyler |
US7074622B2 (en) | 2004-11-15 | 2006-07-11 | Eastman Kodak Company | Method and system for sorting and separating particles |
EP1831684A4 (en) | 2004-11-30 | 2009-03-11 | Veridex Llc | PROGNOSTICS OF LUNG CANCER |
US20060154275A1 (en) | 2004-12-02 | 2006-07-13 | The Board Of Trustees Of The Leland Stanford Junior University | Regulated genes in cervical cancer |
US20060185027A1 (en) | 2004-12-23 | 2006-08-17 | David Bartel | Systems and methods for identifying miRNA targets and for altering miRNA and target expression |
EP1838870A2 (en) | 2004-12-29 | 2007-10-03 | Exiqon A/S | NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF MICRORNAS AND THEIR TARGET MRNAs |
EP1863516A2 (en) | 2005-02-08 | 2007-12-12 | Board of Regents, The University of Texas System | Compositions and methods involving mda-7 for the treatment of cancer |
US7495073B2 (en) | 2005-03-24 | 2009-02-24 | Asia Hepato Gene Company | Short isoform of Annexin A10 at chromosome 4q, termed Annexin 10s (ANXA10s) and methods of use |
US20090062184A1 (en) | 2005-03-24 | 2009-03-05 | Dainippon Sumitomo Pharma Co., Ltd. | Fine particulate preparation comprising complex of nucleic acid molecule and collagen |
GB2425311A (en) * | 2005-04-15 | 2006-10-25 | Ist Superiore Sanita | Micro RNA against kit protein |
EP1874793A4 (en) | 2005-04-15 | 2008-12-24 | Univ Texas | DISTRIBUTION OF SIRNA BY NEUTRAL LIPID COMPOSITIONS |
WO2006119365A2 (en) | 2005-05-02 | 2006-11-09 | Cold Spring Harbor Laboratory | Composition and methods for cancer diagnosis utilizing the mir 17-92 cluster |
US20070072201A1 (en) * | 2005-05-16 | 2007-03-29 | Kohne David E | Method for producing improved nucleic acid oligomer functional homogeneity and functional characteristic information and results and oligomer application results |
US20060265771A1 (en) * | 2005-05-17 | 2006-11-23 | Lewis David L | Monitoring microrna expression and function |
GB0601102D0 (en) | 2006-01-19 | 2006-03-01 | Nuclea Biomarkers Llc | Kinase Peptides And Antibodies |
US20070054287A1 (en) | 2005-05-31 | 2007-03-08 | Applera Corporation | Method for identifying medically important cell populations using micro rna as tissue specific biomarkers |
EP1904110A4 (en) | 2005-06-03 | 2009-02-11 | Southern Adelaide Health Servi | TARGETING CELLS HAVING A MODIFIED EXPRESSION MICROARN |
US20070065844A1 (en) | 2005-06-08 | 2007-03-22 | Massachusetts Institute Of Technology | Solution-based methods for RNA expression profiling |
CA2611507A1 (en) | 2005-06-09 | 2006-12-21 | Epoch Biosciences, Inc. | Improved primer-based amplification methods |
US20060292616A1 (en) | 2005-06-23 | 2006-12-28 | U.S. Genomics, Inc. | Single molecule miRNA-based disease diagnostic methods |
KR101140575B1 (ko) * | 2005-06-30 | 2012-05-02 | 엘지디스플레이 주식회사 | 액정표시장치 검사공정 |
JP5489459B2 (ja) | 2005-08-01 | 2014-05-14 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 乳癌の診断、予後及び治療のためのマイクロrnaに基づいた方法及び組成物 |
IL177006A0 (en) | 2005-08-02 | 2006-12-10 | Veridex Llc | Predicting bone relapse of breast cancer |
US20070213292A1 (en) | 2005-08-10 | 2007-09-13 | The Rockefeller University | Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
US20070041934A1 (en) | 2005-08-12 | 2007-02-22 | Regents Of The University Of Michigan | Dendrimer based compositions and methods of using the same |
WO2007033023A2 (en) | 2005-09-12 | 2007-03-22 | The Ohio State University Research Foundation | Compositions and methods for the diagnosis and therapy of bcl2-associated cancers |
JP2009514874A (ja) | 2005-11-04 | 2009-04-09 | メルク エンド カムパニー インコーポレーテッド | Saha及びペメトレキセドを用いて癌を治療する方法 |
US7390792B2 (en) | 2005-12-15 | 2008-06-24 | Board Of Regents, The University Of Texas System | MicroRNA1 therapies |
US8288354B2 (en) | 2005-12-28 | 2012-10-16 | The Scripps Research Institute | Natural antisense and non-coding RNA transcripts as drug targets |
WO2007073737A1 (en) | 2005-12-29 | 2007-07-05 | Exiqon A/S | Detection of tissue origin of cancer |
ES2465600T3 (es) | 2006-01-05 | 2014-06-06 | The Ohio State University Research Foundation | Métodos basados en microARN y composiciones para el diagnóstico y tratamiento de cánceres sólidos del páncreas |
ES2554531T3 (es) | 2006-01-05 | 2015-12-21 | The Ohio State University Research Foundation | Procedimientos basados en los microARN para el diagnóstico, pronóstico y tratamiento del cáncer de pulmón |
EP2586454B1 (en) | 2006-01-05 | 2014-10-08 | The Ohio State University Research Foundation | MicroRNA expressions abnormalities in pancreatic endocrine and acinar tumors |
US20070259827A1 (en) | 2006-01-25 | 2007-11-08 | University Of Massachusetts | Compositions and methods for enhancing discriminatory RNA interference |
EP1984499B1 (en) | 2006-01-27 | 2015-05-27 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for the use in modulation of micrornas |
CA2638844C (en) | 2006-03-02 | 2016-05-03 | Thomas D. Schmittgen | Microrna expression profile associated with pancreatic cancer |
US7955848B2 (en) | 2006-04-03 | 2011-06-07 | Trustees Of Dartmouth College | MicroRNA biomarkers for human breast and lung cancer |
CA2655355C (en) | 2006-06-16 | 2014-05-06 | Taisho Pharmaceutical Co., Ltd. | Use of rpn2 gene expression inhibitor |
US20080076674A1 (en) | 2006-07-06 | 2008-03-27 | Thomas Litman | Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding RNAs associated with cancer |
CN101657547B (zh) | 2006-07-13 | 2016-04-27 | 俄亥俄州立大学研究基金会 | 用于诊断和治疗结肠癌相关疾病的基于微小rna的方法和组合物 |
WO2008014008A2 (en) | 2006-07-28 | 2008-01-31 | The Johns Hopkins University | Compositions and methods for modulating angiogenesis |
WO2008036741A2 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Mir-200 regulated genes and pathways as targets for therapeutic intervention |
CA2663962A1 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
EP2115138A2 (en) | 2006-09-19 | 2009-11-11 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
US20080131878A1 (en) | 2006-12-05 | 2008-06-05 | Asuragen, Inc. | Compositions and Methods for the Detection of Small RNA |
AU2007333107A1 (en) | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | miR-21 regulated genes and pathways as targets for therapeutic intervention |
CN101627121A (zh) | 2006-12-08 | 2010-01-13 | 奥斯瑞根公司 | 作为治疗干预的靶标的miRNA调控基因和路径 |
EP2104737B1 (en) | 2006-12-08 | 2013-04-10 | Asuragen, INC. | Functions and targets of let-7 micro rnas |
EP2104734A2 (en) | 2006-12-08 | 2009-09-30 | Asuragen, INC. | Mir-20 regulated genes and pathways as targets for therapeutic intervention |
CA2671270A1 (en) | 2006-12-29 | 2008-07-17 | Asuragen, Inc. | Mir-16 regulated genes and pathways as targets for therapeutic intervention |
WO2008088858A2 (en) | 2007-01-17 | 2008-07-24 | The Johns Hopkins University | Compositions and methods featuring micronas for treating neoplasia |
EP2124967A4 (en) | 2007-01-26 | 2011-01-05 | Rosetta Genomics Ltd | COMPOSITIONS AND METHOD FOR THE TREATMENT OF HEMATOPOIETIC MALIGNOMES |
WO2008095096A2 (en) | 2007-01-31 | 2008-08-07 | Immune Disease Institute | Let-7 microrna and mimetics thereof as therapeutics for cancer |
US8741283B2 (en) | 2007-04-20 | 2014-06-03 | Sigma-Tau Rare Diseases, S.A. | Adenosine deaminase anticancer therapy |
EP2142659A4 (en) | 2007-04-30 | 2010-06-09 | Univ Ohio State Res Found | METHOD FOR THE DISTINCTION OF PANCREATIC CANCER OF NORMAL IMMERSION SPECTRUM FUNCTIONS AND CHRONIC IMMERSION IMAGING IGNITION |
CA2686165A1 (en) * | 2007-05-03 | 2008-11-13 | Rosetta Inpharmatics Llc | Compositions comprising mir34 therapeutic agents for treating cancer |
US20090131354A1 (en) | 2007-05-22 | 2009-05-21 | Bader Andreas G | miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
US20090232893A1 (en) | 2007-05-22 | 2009-09-17 | Bader Andreas G | miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
US20090227533A1 (en) | 2007-06-08 | 2009-09-10 | Bader Andreas G | miR-34 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
EP2198050A1 (en) | 2007-09-14 | 2010-06-23 | Asuragen, INC. | Micrornas differentially expressed in cervical cancer and uses thereof |
US7993831B2 (en) | 2007-09-14 | 2011-08-09 | Asuragen, Inc. | Methods of normalization in microRNA detection assays |
WO2009052386A1 (en) | 2007-10-18 | 2009-04-23 | Asuragen, Inc. | Micrornas differentially expressed in lung diseases and uses thereof |
WO2009058907A2 (en) | 2007-10-29 | 2009-05-07 | Isis Pharmaceuticals, Inc. | Targeting micrornas for the treatment of liver cancer |
US8071562B2 (en) * | 2007-12-01 | 2011-12-06 | Mirna Therapeutics, Inc. | MiR-124 regulated genes and pathways as targets for therapeutic intervention |
US20110009469A1 (en) * | 2007-12-05 | 2011-01-13 | The Johns Hopkins University | Compositions and methods of treating neoplasia |
WO2009086156A2 (en) | 2007-12-21 | 2009-07-09 | Asuragen, Inc. | Mir-10 regulated genes and pathways as targets for therapeutic intervention |
EP2260110B1 (en) | 2008-02-08 | 2014-11-12 | Asuragen, INC. | miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS |
EP2096171A1 (en) * | 2008-02-27 | 2009-09-02 | Julius-Maximilians-Universität Würzburg | MicroRNA (miRNA) and down-stream targets for diagnostic and therapeutic purposes |
JP2011517932A (ja) | 2008-02-28 | 2011-06-23 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | ヒト慢性リンパ球性白血病(ccl)と関連するマイクロrnaシグネチャーおよびその使用 |
WO2009111643A2 (en) | 2008-03-06 | 2009-09-11 | Asuragen, Inc. | Microrna markers for recurrence of colorectal cancer |
US8404659B2 (en) * | 2008-03-07 | 2013-03-26 | Santaris Pharma A/S | Pharmaceutical compositions for treatment of MicroRNA related diseases |
WO2009154835A2 (en) | 2008-03-26 | 2009-12-23 | Asuragen, Inc. | Compositions and methods related to mir-16 and therapy of prostate cancer |
WO2009126726A1 (en) | 2008-04-08 | 2009-10-15 | Asuragen, Inc | Methods and compositions for diagnosing and modulating human papillomavirus (hpv) |
EP2285960B1 (en) | 2008-05-08 | 2015-07-08 | Asuragen, INC. | Compositions and methods related to mir-184 modulation of neovascularization or angiogenesis |
US8900627B2 (en) | 2008-06-06 | 2014-12-02 | Mirna Therapeutics, Inc. | Compositions for the in vivo delivery of RNAi agents |
US20100090959A1 (en) | 2008-10-14 | 2010-04-15 | Sony Ericsson Mobile Communications Ab | Forming a keyboard from a combination of keys displayed on a touch sensitive display and on a separate keypad |
US20100179213A1 (en) | 2008-11-11 | 2010-07-15 | Mirna Therapeutics, Inc. | Methods and Compositions Involving miRNAs In Cancer Stem Cells |
WO2010084488A1 (en) * | 2009-01-20 | 2010-07-29 | Ramot At Tel-Aviv University Ltd. | Mir-21 promoter driven targeted cancer therapy |
US7665785B1 (en) | 2009-04-08 | 2010-02-23 | Newton Paul A | Column pipe catch tool |
WO2011050129A1 (en) * | 2009-10-21 | 2011-04-28 | Trustees Of Dartmouth College | Microrna-10 antagonists and microrna-10 targets for use in the treatment of a glioma |
US8841273B2 (en) | 2009-10-28 | 2014-09-23 | Board Of Regents, The University Of Texas System | Methods and compositions for anti-EGFR treatment |
JP5960060B2 (ja) | 2009-11-23 | 2016-08-02 | ジ・オハイオ・ステート・ユニバーシティ | 腫瘍細胞の増殖、遊走および浸潤に影響を与えるために有用な物質および方法 |
JP2013511559A (ja) | 2009-11-24 | 2013-04-04 | ザ ユニバーシティ オブ ウェスタン オーストラリア | 上皮成長因子受容体リガンドのモジュレーション |
US8846631B2 (en) | 2010-01-14 | 2014-09-30 | Regulus Therapeutics Inc. | MicroRNA compositions and methods |
US8933051B2 (en) | 2010-09-30 | 2015-01-13 | University Of Zurich | Treatment of B-cell lymphoma with microRNA |
WO2012106591A1 (en) * | 2011-02-03 | 2012-08-09 | Mirna Therapeutics, Inc. | Synthetic mimics of mir-34 |
WO2012106586A1 (en) * | 2011-02-03 | 2012-08-09 | Mirna Therapeutics, Inc. | Synthetic mimics of mir-124 |
US8785709B2 (en) | 2011-03-30 | 2014-07-22 | University Of Louisville Research Foundation, Inc. | Catalytic isomerisation of linear olefinic hydrocarbons |
UA115652C2 (uk) | 2011-04-25 | 2017-12-11 | Реґюлус Терап'Ютікс Інк. | Сполука, що містить модифікований олігонуклеотид, комплементарна mir-21 |
JP2015501645A (ja) | 2011-12-10 | 2015-01-19 | オハイオ・ステイト・イノベーション・ファウンデーション | 肺がんの腫瘍発生および化学療法耐性を低減するために有用なmiRNAならびに関連する組成物および方法 |
UA116639C2 (uk) | 2012-10-09 | 2018-04-25 | Рег'Юлес Терап'Ютікс Інк. | Способи лікування синдрому альпорта |
EP2968567A2 (en) | 2013-03-15 | 2016-01-20 | Mirna Therapeutics, Inc. | Combination cancer treatments utilizing micrornas and egfr-tki inhibitors |
AU2014302702A1 (en) | 2013-06-24 | 2015-12-17 | Mirna Therapeutics, Inc. | Biomarkers of miR-34 activity |
EP3126496A1 (en) | 2014-04-01 | 2017-02-08 | Mirna Therapeutics, Inc. | Microrna dosing regimens |
-
2005
- 2005-11-14 DK DK10183577.5T patent/DK2302055T3/da active
- 2005-11-14 EP EP14177489.3A patent/EP2808389A1/en not_active Withdrawn
- 2005-11-14 SI SI200531912T patent/SI2302055T1/sl unknown
- 2005-11-14 EP EP10183560A patent/EP2281887A1/en not_active Withdrawn
- 2005-11-14 EP EP10183596.5A patent/EP2302056B1/en not_active Not-in-force
- 2005-11-14 ES ES10183543.7T patent/ES2503743T3/es active Active
- 2005-11-14 JP JP2007541398A patent/JP2008519606A/ja active Pending
- 2005-11-14 EP EP10183456.2A patent/EP2292756B1/en not_active Not-in-force
- 2005-11-14 EP EP10183470A patent/EP2298893A1/en not_active Withdrawn
- 2005-11-14 EP EP10183639A patent/EP2322616A1/en not_active Withdrawn
- 2005-11-14 EP EP10183481.0A patent/EP2281886B1/en not_active Not-in-force
- 2005-11-14 ES ES10183525.4T patent/ES2503740T3/es active Active
- 2005-11-14 EP EP14177498.4A patent/EP2808390A1/en not_active Withdrawn
- 2005-11-14 CA CA002587189A patent/CA2587189A1/en not_active Abandoned
- 2005-11-14 ES ES10183490.1T patent/ES2534301T3/es active Active
- 2005-11-14 EP EP05858321A patent/EP1838852A2/en not_active Withdrawn
- 2005-11-14 ES ES10183481.0T patent/ES2503739T3/es active Active
- 2005-11-14 EP EP10183611.2A patent/EP2281889B1/en not_active Not-in-force
- 2005-11-14 EP EP10183577.5A patent/EP2302055B1/en not_active Revoked
- 2005-11-14 ES ES10183589.0T patent/ES2534303T3/es active Active
- 2005-11-14 CA CA2857881A patent/CA2857881A1/en not_active Abandoned
- 2005-11-14 EP EP10183462.0A patent/EP2302051B1/en not_active Not-in-force
- 2005-11-14 CA CA2857878A patent/CA2857878A1/en not_active Abandoned
- 2005-11-14 EP EP10183451A patent/EP2292755A1/en not_active Withdrawn
- 2005-11-14 EP EP10183543.7A patent/EP2314688B1/en not_active Not-in-force
- 2005-11-14 PL PL10183577T patent/PL2302055T3/pl unknown
- 2005-11-14 ES ES10183567.6T patent/ES2534302T3/es active Active
- 2005-11-14 WO PCT/US2005/041162 patent/WO2006137941A2/en active Application Filing
- 2005-11-14 EP EP10183525.4A patent/EP2298894B1/en not_active Not-in-force
- 2005-11-14 ES ES10183534.6T patent/ES2503741T3/es active Active
- 2005-11-14 ES ES10183538.7T patent/ES2503742T3/es active Active
- 2005-11-14 CA CA2857879A patent/CA2857879A1/en not_active Abandoned
- 2005-11-14 ES ES10183596.5T patent/ES2534304T3/es active Active
- 2005-11-14 CA CA2857880A patent/CA2857880A1/en not_active Abandoned
- 2005-11-14 EP EP10183490.1A patent/EP2302052B1/en not_active Not-in-force
- 2005-11-14 ES ES10183462.0T patent/ES2534300T3/es active Active
- 2005-11-14 CA CA2857901A patent/CA2857901A1/en not_active Abandoned
- 2005-11-14 ES ES10183456.2T patent/ES2503738T3/es active Active
- 2005-11-14 ES ES10183611.2T patent/ES2503765T3/es active Active
- 2005-11-14 CA CA2850323A patent/CA2850323A1/en not_active Abandoned
- 2005-11-14 EP EP10183534.6A patent/EP2302054B1/en not_active Not-in-force
- 2005-11-14 EP EP10183538.7A patent/EP2287303B1/en not_active Not-in-force
- 2005-11-14 US US11/273,640 patent/US8173611B2/en not_active Expired - Fee Related
- 2005-11-14 ES ES10183577.5T patent/ES2507544T3/es active Active
- 2005-11-14 EP EP10183589.0A patent/EP2284265B1/en not_active Not-in-force
- 2005-11-14 EP EP10183567.6A patent/EP2281888B1/en not_active Not-in-force
- 2005-11-14 EP EP10183515A patent/EP2302053A1/en not_active Withdrawn
- 2005-11-14 AU AU2005333165A patent/AU2005333165B2/en not_active Ceased
-
2007
- 2007-08-10 US US11/837,487 patent/US8563708B2/en not_active Expired - Fee Related
- 2007-08-10 US US11/837,490 patent/US7960359B2/en not_active Expired - Fee Related
- 2007-08-10 US US11/837,488 patent/US8058250B2/en not_active Expired - Fee Related
-
2010
- 2010-02-23 JP JP2010036925A patent/JP5389690B2/ja not_active Expired - Fee Related
-
2011
- 2011-07-25 US US13/190,232 patent/US20110313025A1/en not_active Abandoned
- 2011-11-17 US US13/299,255 patent/US8946177B2/en not_active Expired - Fee Related
-
2012
- 2012-07-05 JP JP2012150997A patent/JP5596085B2/ja not_active Expired - Fee Related
-
2013
- 2013-02-07 US US13/761,284 patent/US20130143945A1/en not_active Abandoned
- 2013-05-03 US US13/887,008 patent/US20130303591A1/en not_active Abandoned
- 2013-08-28 US US14/012,302 patent/US8765709B2/en not_active Expired - Fee Related
- 2013-09-05 JP JP2013183871A patent/JP5620556B2/ja not_active Expired - Fee Related
-
2014
- 2014-04-16 US US14/254,532 patent/US9051571B2/en not_active Expired - Fee Related
- 2014-05-26 JP JP2014107664A patent/JP2014217381A/ja active Pending
- 2014-07-24 JP JP2014150365A patent/JP2014223080A/ja active Pending
- 2014-07-24 JP JP2014150384A patent/JP2014217386A/ja active Pending
- 2014-07-24 JP JP2014150321A patent/JP2014217384A/ja active Pending
- 2014-07-24 JP JP2014150350A patent/JP2014217385A/ja active Pending
- 2014-07-24 JP JP2014150414A patent/JP2014217387A/ja active Pending
- 2014-08-13 US US14/459,192 patent/US20140348908A1/en not_active Abandoned
- 2014-08-13 US US14/459,074 patent/US9068219B2/en not_active Expired - Fee Related
- 2014-08-13 US US14/459,158 patent/US20150005366A1/en not_active Abandoned
- 2014-08-13 US US14/459,182 patent/US9382537B2/en not_active Expired - Fee Related
- 2014-08-13 US US14/459,119 patent/US20140348907A1/en not_active Abandoned
-
2015
- 2015-05-14 US US14/712,591 patent/US9506061B2/en not_active Expired - Fee Related
- 2015-06-03 HK HK15105287.4A patent/HK1204656A1/zh unknown
- 2015-06-09 US US14/735,046 patent/US20150275213A1/en not_active Abandoned
- 2015-06-12 US US14/738,646 patent/US20150342981A1/en not_active Abandoned
- 2015-06-12 US US14/738,734 patent/US20150344883A1/en not_active Abandoned
- 2015-06-12 US US14/738,716 patent/US20150284720A1/en not_active Abandoned
- 2015-06-12 US US14/738,728 patent/US20150299705A1/en not_active Abandoned
- 2015-06-12 US US14/738,706 patent/US20150284719A1/en not_active Abandoned
- 2015-06-16 US US14/741,064 patent/US9447414B2/en not_active Expired - Fee Related
- 2015-08-31 US US14/841,377 patent/US20150361431A1/en not_active Abandoned
-
2016
- 2016-03-31 JP JP2016069966A patent/JP2016165292A/ja active Pending
- 2016-10-20 US US15/298,781 patent/US20170037404A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1204656A1 (zh) | 涉及 抑制劑分子的方法和組合物 | |
EP1954708A4 (en) | METHODS AND COMPOSITIONS IN INTRINSIC GENES | |
PL2010676T3 (pl) | Sposób i zestaw do molekularnego ilościowego oznaczania chromosomów | |
EP2035014A4 (en) | FUCOIDANE PREPARATIONS AND METHODS | |
PT2101766T (pt) | Composições e métodos de utilização de (r)-pramipexole | |
GB0522287D0 (en) | Method and compositions | |
EP1895838A4 (en) | COMPOSITIONS AND METHODS | |
GB0604973D0 (en) | Purification method and kit | |
GB0525314D0 (en) | Method and composition | |
EP2101731A4 (en) | PROCESSES AND COMPOSITIONS WITH END OXIFES | |
HK1223968A1 (zh) | 狂犬病病毒組合物和方法 | |
GB0603295D0 (en) | Methods and kits | |
IL247957A0 (en) | Anti-ephrinb2 antibodies and methods of using them | |
PL2101766T3 (pl) | Kompozycje i sposoby stosowania (R)-pramipeksolu | |
HK1137756A1 (zh) | 取代二氫吡唑啉酮和它們作爲 -脯氨酰- -羥化酶抑制劑的用途 | |
EP2088865A4 (en) | METHODS AND COMPOSITIONS AROUND GUGGULPHOSPHOLIPIDS | |
GB0617171D0 (en) | Novel compositions and methods | |
GB0524927D0 (en) | Compositions and method | |
EP1807512A4 (en) | COMPOSITIONS AND METHODS FOR REVERSE TRANSCRIPTION | |
EP2132251A4 (en) | COMPOSITION AND METHOD | |
ZA200802969B (en) | Composition and method | |
GB0625208D0 (en) | Composition and method | |
GB0522655D0 (en) | Composition and method | |
GB0511235D0 (en) | Compositions and method | |
GB0501348D0 (en) | Compositions and methods |